Quarterlytics / Consumer Defensive / Beverages - Non-Alcoholic / Celsius

Celsius

celh · NASDAQ Consumer Defensive
Claim this profile
Ticker celh
Exchange NASDAQ
Sector Consumer Defensive
Industry Beverages - Non-Alcoholic
Employees 51-200
← All annual reports
FY2008 Annual Report · Celsius
Sign in to download
Loading PDF…
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-K

[X] ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended: December 31, 2008

[ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

CELSIUS HOLDINGS, INC.
(Exact name of registrant as specified in its charter)

NEVADA
(State or other jurisdiction of  incorporation)

333-129847
(Commission File Number)

20-2745790
(IRS Employer Identification No.)

140 NE 4th Avenue, Suite C
Delray Beach, FL 33483
(Address of principal executive offices) (Zip Code)

(561) 276-2239
(Registrant’s telephone number, including area code)

Securities registered under Section 12(b) of the Exchange Act: None
Securities registered under Section 12(g) of the Exchange Act:  Common Stock, par value $0.001

(Former name, former address and former fiscal year, if changed since last report)

Check whether the issuer has (1) filed all reports required to be files by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period
the Company was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]

Check if there is no disclosure of delinquent filers in response to Item 405 of Regulation S-B contained in this form, and no disclosure will be contained, to the best of
Company's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. [X]

Indicate  by  check  mark  whether  the  registrant  is  a  large  accelerated  filer,  an  accelerated  filer,  a  non-accelerated  filer,  or  a  smaller  reporting  company.  See  the
definitions of "large accelerated filer,""accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act. (Check one):

[ ] Large accelerated filer   [ ] Accelerated filer    [ ] Non-accelerated filer     [ X ] Smaller reporting company

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes [ ] No [X]

State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity
was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter:
$9.5 million.

Indicate the number of shares outstanding of each of the registrant's classes of common stock, as of the latest practicable date 148,749,354 as of March 2, 2009.

 
 
 
 
 
 
 
 
 
 
ITEM 1             DESCRIPTION OF BUSINESS

Formation

The  Company  was  incorporated  in  the  State  of  Nevada  on April  26,  2005  under  the  name  "Vector  Ventures  Corp.”  The  Company  changed  its  name  to  "Celsius
Holdings, Inc.” on December 26, 2006. On December 26, 2006, the Company completed a 4 for 1 forward split of its issued and outstanding share capital.

We  are  a  holding  company  and  carry  on  no  operating  business  except  through  our  direct  wholly  owned  subsidiaries,  Celsius,  Inc.  and  Celsius  Netshipments,  Inc.
Celsius, Inc. was incorporated in Nevada on January 18, 2007, and merged with Elite FX, Inc. ("Elite”) on January 26, 2007 (the "Merger”), which was incorporated
in Florida on April 22, 2004. For financial accounting purposes, the Merger was treated as a recapitalization of Celsius Holdings, Inc (the "Company”) with the former
stockholders of the Celsius Holdings, Inc retaining approximately 24.6% of the outstanding stock. This transaction has been accounted for as a reverse acquisition and
accordingly the transaction has been treated as a recapitalization of Elite, with Elite as the accounting acquirer. The historical financial statements are a continuation
of  the  financial  statements  of  the  accounting  acquirer,  and  any  difference  of  the  capital  structure  of  the  merged  entity  as  compared  to  the  accounting  acquirer’s
historical capital structure is due to the recapitalization of the acquired entity. Celsius Netshipments, Inc was incorporated in Florida on March 29, 2007. We expect
Celsius and Celsius Netshipments will generate substantially all of our operating revenue and expenses.

The Company has not been involved in any bankruptcy, receivership or similar proceeding nor has there been any material reclassification or merger, consolidation or
purchase or sale of a significant amount of assets not in the ordinary course of business.

Historical Information

The Company was formed as an exploration stage company, meaning we were formed to engage in the search for mineral deposits (reserves) which are not in either
the development or production stage. We issued 2,000,000 units (8,000,000 post split units) to thirty-five (35) unrelated Stockholders for cash valued at $0.05 per unit
pursuant to our SB-2 offering which closed on March 30, 2006. Each unit consisted of four shares and eight (8) share purchase warrants after taking into account the
forward split of the Company completed on December 26, 2006. Each share purchase warrant was valid for a period of two years from the date of the prospectus,
expiring on January 20, 2008 and was exercisable at a price of $0.025 per share taking into account the forward split.  All warrants issued were exercised prior to
January 26, 2007.

Once  we  obtained  funding  under  our  March  30,  2006  SB-2  offering  we  began  phase  I  exploration  on  our  one  property  in  the  Company's  portfolio,  the  One  Gun
Project, consisting of 9 unit mineral claims having a total surface area of approximately 473 acres. On October 23, 2006 we received the results of the initial campaign
and though these were generally poor, the Dollar Ext Zone was located and good geological information was gained. Given there was a strong possibility that the One
Gun  Project  claims  would  not  contain  any  reserves  we  began  to  look  at  other  potential  mineral  properties  to  explore  or  other  possible  business  opportunities.  In
November 2006, we arranged for a bridge loan to Elite FX, Inc., a Florida corporation involved in the beverage industry ("Elite”).

On January 24, 2007, we entered into a merger agreement and plan of reorganization (the "Merger Agreement”) with Celsius, Inc, Elite and Stephen C. Haley, (as
the "Indemnifying Officer” and "Securityholder Agent” of Elite) pursuant to which Elite was merged into Celsius, Inc. and became a wholly-owned subsidiary of the
Company on January 26, 2007 (the "Merger”).

1

 
 
 
 
 
 
 
 
 
As of closing the Merger Agreement, we changed our business to the business of Elite and have ceased to be an exploration stage company.

Current Business of the Company

We are in the business of producing, distributing and marketing functional beverages.

We operate in the  United  States through our wholly-owned subsidiaries,  Celsius  Inc., which acquired the operating business of  Elite through a reverse merger on
January 26, 2007, and Celsius Netshipments, Inc. Celsius, Inc. is in the business of developing and marketing bottled drinks in the functional beverage category of the
soft  drink  industry.  Celsius®  was  the  Company’s  first  commercially  available  product.  Celsius  is  a  calorie  burning  beverage.  Celsius  is  currently  available  in  five
sparkling  flavors:  cola,  ginger  ale,  lemon/lime,  orange  and  wild  berry,  and  in  two  non-carbonated  green  teas  with  the  flavor  of  peach/mango  and  raspberry/acai.
Celsius Netshipments, Inc., incorporated in Florida on March 29, 2007, distributes the Celsius beverage via the internet. Our focus is on increasing sales of our existing
products.

We  are  using  Celsius  as  a  means  to  attract  and  sign  up  direct-store-delivery  ("DSD”)  distributors  across  the  United  States  of  America.  DSD  distributors  are
wholesalers/distributors that purchase product, store it in their warehouse and then using their own trucks sell and deliver the product direct to retailers and their store
shelves or cooler doors. During this process the DSD distributors make sure that the product is properly placed on the shelves, manage the invoicing and collection
process and train local personnel. Most retailers that sell Celsius prefer this method to get beverages to their stores. There are some retailers that prefer a different
method  called  direct-to-retailer  ("DTR”).  In  this  scenario,  the  retailer  is  buying  direct  from  the  brand  manufacturer  and  the  product  is  delivered  to  the  retailer’s
warehousing system. The retailer is then responsible to properly stock the product and get it to the shelves. Our strategy is to cover the country with a network of
DSD distributors. This allows us to sell to retailer chains that prefer the DSD method and whose store locations span across distributor boundaries. We believe that a
strong DSD network gives us a path to get to the smaller independent retailers who are too small to have their own warehousing and distribution systems and thus can
only get their beverages from distributors. Our strategy of building a DSD network will not prohibit us from distributing via DTR when a retailer requests or requires
it.

We have currently signed up distributors in many of the larger markets in the US (Chicago, Detroit, Boston, Los Angeles, etc). We expect that it will take at least until
the end of 2009 before we have most of the United States covered.

Our experience has shown that it takes about two to three months to bring on a DSD distributor. From initial interest to actual purchase order and kick off or the
launch in that area, the steps include a physical meeting or two to explain the brand, target markets and our marketing plans. As we add sales reps we are able to do
more of these activities at a time and speed up the process.

Our  principal  executive  offices  are  located  at  140  NE  4th  Avenue,  Delray  Beach,  Florida  33483.  Our  telephone  number  is  (561)  276-2239  and  our  website  is
http://www.celsius.com. The information contained on our web site does not constitute part of, nor is it incorporated by reference into, this 10-K annual report.

2

 
 
 
 
 
 
 
 
 
Industry Overview

The functional beverage market includes a wide variety of beverages with one or more added ingredients to satisfy a physical or functional need, which often carries
a unique and sophisticated imagery and a premium price tag.  This category includes: The five fastest-growing segments of the functional beverage market include:
herb-enhanced fruit drinks, ready-to-drink (RTD) teas, sports drinks, energy drinks, and single-serve (SS) fresh juice.

Our Products

In 2005, Elite introduced Celsius to the beverage marketplace and it is our first product. Four clinical studies have shown that a single 12oz serving of Celsius raises
metabolism over a 3 to 4 hour period. Quantitatively, the energy expenditure was on average over 100 calories from a single serving.

It is our belief that clinical studies proving product claims will become more important as more and more beverages are marketed with functional claims. Celsius was
one of the first beverages to be launched along with a clinical study. Celsius is also one of very few that has clinical research on the actual product. Some beverage
companies that do mention studies backing their claims are actually referencing independent studies conducted on one or more of the ingredients in the product and
not the actual product itself. We believe that it is important and will become more important to have studies on the actual product.

Two different research organizations have shown the calorie burning capability of Celsius in two separate clinical studies. This product line, which is referred to as our
"core  brand”,  competes  in  the  "functional  beverage”  segment  of  the  beverage  marketplace  with  distinctive  flavors  and  packaging.  This  segment  includes  herb-
enhanced fruit drinks, ready-to-drink (RTD) teas, sports drinks, energy drinks, and single-serve (SS) fresh juice.

We currently offer Celsius in five sparkling flavors: cola, ginger ale, lemon/lime, orange and wild berry, and in two non-carbonated green teas flavors: peach/mango
and raspberry/acai. We have developed and own the formula for this product including the flavoring. The formulation and flavors for these products are produced
under contract by concentrate suppliers.

Celsius is currently packaged in distinctive (12 fl oz) cans and glass bottles with full-body shrink-wrapped labels both of which are in vivid colors in abstract patterns
and cover the entire product to create a strong on-shelf impact. The cans and bottles are sold in single units or in packages of four. The graphics and clinically tested
product are important elements to Celsius and help justify the premium pricing of $1.79 to $2.29 per bottle/can. In 2008, we decided to phase out the sales of bottles,
and we still have some inventory left that is being sold, but no new production is scheduled.

Clinical Studies

We have funded four U.S. based clinical studies for Celsius. Each conducted by research organizations and each studied the total Celsius formula. The first study
was  conducted  by  the  Ohio  Research  Group  of  Exercise  Science  and  Sports  Nutrition.  The  second,  third  and  fourth  studies  were  conducted  by  the  Applied
Biochemistry & Molecular Physiology Laboratory of the University of Oklahoma. We entered into a contract with the University of Oklahoma to pay for part of the
cost of the clinical study. In addition, we provided Celsius beverage for the studies and paid for the placebo beverage used in the studies. None of our officers or
directors is in any way affiliated with either of the two research organizations.

3

 
 
 
 
 
 
 
 
 
 
 
The first study was conducted by the Ohio Research Group of Exercise Science & Sports Nutrition, which is a multidisciplinary clinical research team dedicated to
exploring the relationship between exercise, nutrition, dietary supplements and health, www.ohioresearchgroup.com. This placebo-controlled, double-blind cross-over
study  compared  the  effects  of  Celsius  and  the  placebo  on  metabolic  rate.  Twenty-two  participants  were  randomly  assigned  to  ingest  a  twelve  ounce  serving  of
Celsius and on a separate day a serving of twelve ounces of Diet Coke®. All subjects completed both trials using a randomized, counterbalanced design. Randomized
means  that  subjects  were  selected  for  each  group  randomly  to  ensure  that  the  different  treatments  were  statistically  equivalent.  Counterbalancing  means  that
individuals  in  one  group  drank  the  placebo  on  the  first  day  and  drank  Celsius  on  the  second  day.  The  other  group  did  the  opposite.  Counterbalancing  is  a  design
method that is used to control ‘order effects’. In other words, to make sure the order that subjects were served does not impact the results and analysis.

Metabolic rate (via indirect calorimetry, measurements taken from breaths into and out of calorimeter) and substrate oxidation (via respiratory exchange ratios) were
measured at baseline (pre-ingestion) and for 10 minutes at the end of each hour for 3 hours post-ingestion. The results showed an average increase of metabolism of
twelve percent over the three hour period, compared to statistically insignificant change for the control group. Metabolic rate, or metabolism, is the rate at which the
body expends energy. This is also referred to as the "caloric burn rate”. Indirect calorimetry calculates heat that living organisms produce from their production of
carbon dioxide. It is called "indirect” because the caloric burn rate is calculated from a measurement of oxygen uptake. Direct calorimetry would involve the subject
being  placed  inside  the  calorimeter  for  the  measurement  to  determine  the  heat  being  produced.  Respiratory  Exchange  Ratio  is  the  ratio  oxygen  taken  in  a  breath
compared to the carbon dioxide breathed out in one breath or exchange. Measuring this ratio can be used for estimating which substrate (fuel such as carbohydrate or
fat) is being metabolized or ‘oxidized’ to supply the body with energy.

The second study was conducted by the Applied Biochemistry & Molecular Physiology Laboratory of University of Oklahoma. This blinded, placebo-controlled study
was conducted on a total of sixty men and women of normal weight. An equal number of participants were separated into two groups to compare one serving (12oz)
of Celsius to a placebo of the same amount. According to the study, those subjects consuming Celsius burned significantly more calories versus those consuming the
placebo, over a three hour period. The study confirmed that over the three hour period, subjects consuming a single serving of Celsius burned sixty-five percent more
calories than those consuming the placebo beverage and burned an average of more than one hundred calories compared to placebo. These results were statistically
significant.

The third study, also conducted by the Applied  Biochemistry &  Molecular  Physiology  Laboratory of  University of  Oklahoma, extended our second study with the
same  group  of  sixty  individuals  and  protocol  for  28  days  and  showed  the  same  statistical  significance  of  increased  calorie  burn  (minimal  attenuation).  While  the
University of Oklahoma study did extend for 28 days, more testing would be needed for long term analysis of the Celsius calorie burning effects. Also, these studies
were on relatively small numbers of subjects, they have statistically significant results. Additional studies on a larger number and wider range of body compositions
can be considered to further the analysis.

4

 
 
 
 
 
Our fourth study, also conducted by the Applied Biochemistry & Molecular Physiology Laboratory of University of Oklahoma, combined Celsius with exercise. This
10-week  placebo-controlled,  randomized  and  blinded  study  was  conducted  on  a  total  of  37  subjects.  Participants  were  randomly  assigned  into  one  of  two  groups:
Group  1  consumed  one  serving  of  Celsius  per  day,  and  Group  2  consumed  one  serving  of  an  identically  flavored  and  labeled  placebo  beverage.  Both  groups
participated in 10 weeks of combined aerobic and weight training, following the American College of Sports Medicine guidelines of training for previously sedentary
adults.  The  results  showed  that  consuming  a  single  serving  of  Celsius  prior  to  exercising  may  enhance  the  positive  adaptations  of  exercise  on  body  composition,
cardio-respiratory fitness and endurance performance. The researchers of the study presented its preliminary results at the annual meeting of the International Society
of Sports Nutrition in June 2008. According to the presentation and abstract, subjects consuming a single serving of Celsius lost significantly more fat mass and gained
significantly more muscle mass than those subjects consuming the placebo - a 93.8% greater loss in fat and 50% greater gain in muscle mass, respectively. The study
also  confirmed  that  subjects  consuming  Celsius  significantly  improved  measures  of  cardio-respiratory  fitness  and  the  ability  to  delay  the  onset  of  fatigue  when
exercising to exhaustion.

Manufacture and Supply of Our Products

Our products are produced by beverage co-packers. A co-packer is a manufacturing plant that provides the service of filling bottles or cans for the brand owner. We
believe the benefit of using co-packer is we do not have to invest in the production facility and can focus our resources on brand development, sales and marketing. It
also  allows  us  produce  in  multiple  locations  strategically  placed  throughout  the  country.  Currently  our  products  are  produced  in  Mooresville,  North  Carolina,  and
Monroe, Wisconsin. We usually produce about 25,000 cases (24 units per case) of Celsius in a production run. We supply all the ingredients and packaging materials.
The co-pack facility assembles our products and charges us a fee, by the case. We follow a "fill as needed” manufacturing model to the best of our ability and we
have no significant backlog of orders. The shelf life of the Celsius is specified as 14 months for both cans and bottles.

Substantially all of the raw materials used in the preparation, bottling and packaging of our products are purchased by us or by our contract packers in accordance
with  our  specifications.  Generally,  we  obtain  the  ingredients  used  in  our  products  from  domestic  suppliers  and  each  ingredient  has  several  reliable  suppliers.  The
ingredients  in  the  Celsius  Beverage  include Green  Tea (EGCG),  Ginger (from the root),  Caffeine,  B-Vitamins,  Vitamin  C,  Taurine,  Guarana,  Chromium,  Calcium,
Glucuronolactone and Sucralose, and Celsius is packaged using a supplements facts panel. We have no major supply contracts with any of our suppliers. As a general
policy, we pick ingredients in the development of our products that have multiple suppliers and are common ingredients. This provides a level of protection against a
major supply constriction or calamity.

We believe that if we grow, we will be able to keep up with increased production demands. We believe that our current co-packing arrangement has the capacity to
handle increased business we may face in the next twelve (12) months. To the extent that any significant increase in business requires us to supplement or substitute
our  current  co-packer,  we  believe  that  there  are  readily  available  alternatives,  so  that  there  would  not  be  a  significant  delay  or  interruption  in  fulfilling  orders  and
delivery of our products. In addition, we do not believe that growth will result in any significant difficulty or delay in obtaining raw materials, ingredients or finished
product.

Our Primary Markets

We target a niche in the soft drink industry known as functional beverages. The soft drink industry generally characterizes beverages as being made with nutritional
and mineral additives, with upscale packaging, and often creating and utilizing new and unique flavors and flavor combinations.

5

 
 
 
 
 
 
 
 
Celsius is ultimately sold across many retail segments or channels. We group the grocery, convenience, drug, mass and club channel into one group as major channels.
We classify health clubs, spas, gyms etc as our Health and Fitness channel. We are expanding our distribution into each channel. We reach these channels through
sales to DSD distributors or brokers, who in turn sell to different channels or through sales to DTR customers. We cannot accurately estimate how much is sold in
each channel, because the sales information comes through our  DSD distributors’ sales information, and each one may or may not utilize the same sales channel
classification as we do.

Distribution, Sales and Marketing

Our  predecessor  Elite  initiated  a  grassroots  marketing  strategy  to  launch  Celsius  in  2005.    This  marketing  strategy  leveraged  the  significant  media  interest  in  the
results of the clinical trial which confirmed the product’s functional benefit.  Celsius was subsequently unveiled at the International Society for Sports Nutrition (ISSN)
annual scientific symposium in June of 2005.  Media interest in the category-creating positioning and clinical proof generated national coverage. Over 200 TV news
stations aired over 800 segments highlighting Celsius, as well as articles in a multitude of news papers and magazines and their websites.

Once initial distribution was achieved in the southeastern  United  States, a top-tier branding agency was retained to develop a comprehensive integrated marketing
communications  program  for  use  in  regional  and  national  roll-out.    These  materials  included  Point  of  Sale  graphics,  billboards,  print  advertising  layouts,  coupon
graphics,  radio  scripts  and  other  creative  components.  Over  time  the  point  of  sale  materials  have  evolved  and  changed  with  input  from  employees  and  outside
consultants. All of these are not used in every market but provide a good foundation of promotional materials as we do launch in a specific area or with a specific
distributor.

Celsius and the Beverage Supply Chain

Consumers  buy  their  beverages  in  various  ways.  Most  beverages  are  purchased  at  retailers  which  can  be  segmented  by  type  of  store  such  as  grocery,  drug,
convenience/gas, mass and club.  Some health focused beverages can be purchased in gyms, health clubs and spas.  Some beverages are purchased from vending
machines and some consumers order beverages over the internet to be delivered to their homes or offices.

Celsius is a brand that can sell through all of these channels and we are doing so now in the  US.  We intend to grow our volumes through each channel through
various means. We classify the channels into four sub-groups, Major Channel (grocery, drug, convenience, club and mass), Health & Fitness (gyms, health clubs, etc),
Vending and Internet Sales. If we grow our distribution network, we believe the largest percentage of sales will come from the major channels.

Celsius is also being sold internationally and we will group those sales in two large groups, export (an importer buys the product and resells it) and license (a bottler
will license the rights to produce locally and then they will sell and distribute in their respective countries.) In the immediate future we are focused on the US market,
however, we will continue to respond to international interest and inquiries.

6

 
 
 
 
 
 
 
 
 
 
Selling to and Growing the DSD Distribution Network

We  are  currently  marketing  to  distributors  using  a  number  of  marketing  strategies,  including  direct  solicitation,  telemarketing,  trade  advertising  and  trade  show
exhibition. These distributors include established distributors of other beverages such as beer, energy drinks, soft drinks, water and ready to drink teas. Our distributors
sell our products directly to retail chains, convenience stores, drugstores and mainstream supermarkets for sale to the public.  We maintain direct contact with the
distributors through our in-house sales managers.  In limited markets, where the use of our direct sales managers is not cost-effective, we utilize food brokers and
outside representatives.  A DSD distributor will have a defined territory (usually determined by a set of counties).  In many cases we will work with the distributor
under a contractual arrangement. For the right to sell Celsius in their territory, they agree to certain duties of which one is a quarterly or yearly minimum of sales.

Distributors sell to the stores in their area. In many cases, the distributor services a chain of retail stores that have a corporate office or buying office that is outside
their territory. We make the calls on those stores either on our own or through the neighboring distributor that does have the buying office in their territory. See Selling
to Retail Stores for more detail.

Selling to Retail Stores

We are currently marketing to retail stores by utilizing trade shows, trade advertising, telemarketing, direct mail pieces and direct contact with retailers we believe
would be interested in our products. Our regional sales managers, working with our National Accounts personnel, will make sales calls to and meet with the buyers of
these larger chains. Our strategy is for the chain to be serviced by our DSD distributors or by brokers. Examples of major retail chains that carry Celsius and get their
product through our DSD distributors include: Hannafords (Northeast), Walgreens (Georgia, Michigan and Ohio), Meijers (Michigan), QFC (Washington) and through
brokers include Walgreens (Florida). In some cases, the retailers are so large that they have established their own distribution and warehousing systems and in these
cases we will sell DTR. Examples of these are Vitamin Shoppes (across United States) and Krogers and Raley’s (California).

Sales Direct to Consumers (Internet Sales)

Consumers are able to purchase Celsius directly from our website. We have customers that choose this method of purchase and delivery in all 48 contiguous states
and a few sales in Hawaii and Alaska. We are not focused on building this channel but we believe it helps us build brand awareness in areas that do not have strong
retailer or distributor presence yet.

Marketing to Consumers

Advertising.  We  intend  to  utilize  several  marketing  strategies  to  market  directly  to  consumers. Advertising  in  targeted  consumer  magazines  aimed  at  consumers
interested  in  weight  loss,  diet  and  fitness,  in-store  discounts  on  the  products,  in-store  product  demonstration,  street  corner  sampling,  coupon  advertising,  consumer
trade shows, event sponsoring and our website http://www.celsius.com are all among consumer-direct marketing devices we intend to utilize in the future.

In-Store Displays. As part of our marketing efforts, we intend to offer in-store displays in key markets. We also believe that our unique packaging is an important
part of making successful products.

Seasonality of Sales

Sales  of  our  beverages  are  seasonal,  with  the  highest  sales  volumes  generally  occurring  in  the  second  and  third  fiscal  quarters,  which  correspond  to  the  warmer
months of the year in our major markets.

7

 
 
 
 
 
 
 
 
 
 
 
 
 
Competition

Our products compete broadly with all beverages available to consumers. The beverage market is highly competitive, and includes international, national, regional and
local producers and distributors, many of whom have greater financial, management and other resources than us.

Our direct competitors in the functional beverage market include but are not limited to The Coca-Cola Company, Cadbury Schweppes, PepsiCo, Inc., Nestlé, Waters
North America, Inc., Hansen Natural Corp. and Red Bull.

While we believe that we offer a unique product which will be able to compete favorably in this marketplace, the expansion of competitors in the functional beverage
market, along with the expansion of our competitor’s products, many of whom have substantially greater marketing, cash, distribution, technical and other resources
than we do, may impact our products’ ultimate sales to distributors and consumers.

Proprietary Rights

In connection with our acquisition of the business of Elite, we, through our wholly owned subsidiary Celsius, Inc., have acquired the Celsius® trademark, which is
registered in the United States.

We will continue to take appropriate measures, such as entering into confidentiality agreements with our contract packers and exclusivity agreements with our flavor
houses,  to  maintain  the  secrecy  and  proprietary  nature  of  our  flavor  concentrates.  We  consider  our  trademarks  and  flavor  concentrate  trade  secrets  to  be  of
considerable value and importance to our business. No successful challenges to our registered trademarks have arisen and we have no reason to believe that any such
challenges will arise in the future.

Research and Development

Throughout 2008, the Company focused its full efforts on Celsius, limiting new product development to flavor line extensions of this high-potential brand.  Two new
flavors, peach/mango and raspberry/acai, were recently developed and launched in September 2008.

Beyond 2008, we intend to target development and launch one high-potential new product per year.  We followed a detailed process to identify, qualify and develop
Celsius. As  our  distribution  network  increases,  we  are  beginning  the  process  for  the  next  brand  or  product  extension  that  we  plan  to  launch  into  the  distribution
network. We have during 2008 engaged other companies in product development for us and will continue this process in 2009.

Government Regulation

The production, distribution and sale of our products in the United States is subject to the Federal Food, Drug and Cosmetic Act, the Dietary Supplement Health
and  Education  Act  of  1994,  the Occupational  Safety  and  Health  Act,  various  environmental  statutes  and  various  other  federal,  state  and  local  statutes  and
regulations  applicable  to  the  production,  transportation,  sale,  safety,  advertising,  labeling  and  ingredients  of  such  products.  California  law  requires  that  a  specific
warning appear on any product that contains a component listed by California as having been found to cause cancer or birth defects. The law exposes all food and
beverage producers to the possibility of having to provide warnings on their products because the law recognizes no generally applicable quantitative thresholds below
which a warning is not required. Consequently, even trace amounts of listed components can expose affected products to the prospect of warning labels. Products
containing listed substances that occur naturally in the product or that are contributed to the product solely by a municipal water supply are generally exempt from the
warning requirement. While none of our products are required to display warnings under this law, we cannot predict whether an important component of any of our
products might be added to the California list in the future. We also are unable to predict whether or to what extent a warning under this law would have an impact on
costs or sales of our products.

8

 
 
 
 
 
 
 
 
 
 
 
 
 
Measures  have  been  enacted  in  various  localities  and  states  that  require  that  a  deposit  be  charged  for  certain  non-refillable  beverage  containers.  The  precise
requirements imposed by these measures vary. Other deposit, recycling or product stewardship proposals have been introduced in certain states and localities and in
Congress, and we anticipate that similar legislation or regulations may be proposed in the future at the local, state and federal levels, both in the United States and
elsewhere.

Our facilities in the United States are subject to federal, state and local environmental laws and regulations. Compliance with these provisions has not had, and we do
not expect such compliance to have, any material adverse effect upon our capital expenditures, net income or competitive position.

Environmental Matters

Based on our current operations, environmental protection requirements do not have a significant financial and operational effect on the capital expenditures, earnings
and competitive position of our company in the current financial year and are not expected to have a significant effect in the reasonably foreseeable future.

Employees

As of December 31, 2008, we employed a total of 28 employees on a full-time basis.  Of our 28 employees, we employ four in administrative capacities and twenty
four persons in sales and marketing capacities. We have not experienced any work stoppages.  We have not entered into any collective bargaining agreements. We
consider  our  relations  with  employees  to  be  good.  We  also  contract  with  a  number  of  persons  independently,  who  at  time  to  time  will  work  for  us  at  events  and
samplings.

ITEM 2             DESCRIPTION OF PROPERTY

Our executive offices are located at 140 NE 4th Avenue, Suite B and C, Delray Beach, FL 33483. We are currently being provided with space at this location by an
unrelated third party, pursuant to a twelve (12) month lease for $6,717 per month.

The Company has no warehouses or other facilities. We produce our products through the following packing, or co-pack, facilities: Minhas Craft Brewery (Monroe,
Wisconsin) for bottles and Carolina Beer & Beverage (Mooresville, North Carolina) for cans. We have approved other facilities for co-packing of bottles and cans in
New York, Tennessee and Oregon but are currently not producing product at these facilities.

ITEM 3             LEGAL PROCEEDINGS

We know of no material, active or pending legal proceedings against our Company, nor are we involved as a plaintiff in any material proceeding or pending litigation.
There are no proceedings in which any of our directors, officers or affiliates, or any registered or beneficial stockholder, is an adverse party or has a material interest
adverse to our interest.

ITEM 4             SUBMISSIONS OF MATTERS TO A VOTE OF SECURITIES HOLDERS

None.

9

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PART II

ITEM 5             MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS

Market Information

Our Common Stock was first quoted on the Over-the-Counter Bulletin Board on September 11, 2006, under the trading symbol "VCVC”. Our trading symbol was
changed on December 26, 2006 to "CSUH”. The following quotations reflect the high and low bids for our Common Stock based on inter-dealer prices, without retail
mark-up, mark-down or commission and may not represent actual transactions. The high and low bid prices for our common shares (obtained from otcbb.com) for
each full financial quarter since being quoted were as follows:

 Quarter Ended(1)
 December 31, 2008
 September 30, 2008
 June 30, 2008
 March 31, 2008
 December 31, 2007
 September 30, 2007
 June 30, 2007
 March 31, 2007

High
$0.08
$0.15
$0.19
$0.28
$0.65
$1.31
$1.78
$3.67

Low
$0.03
$0.05
$0.08
$0.10
$0.13
$0.47
$0.62
$1.20

Notes:
(1)

The quotations above reflect inter-dealer prices, without retail mark-up, mark-down or commission and may not represent actual transactions.

Holders of Our Common and Preferred Stock

As of March 2, 2009, we have approximately 45 common stock holders of record, and more than 5,000 beneficial owners holding our common stock in their brokers'
name. We have one holder of record of our Preferred Stock.

Dividends

The  Company  has  never  declared  nor  paid  any  cash  dividends  on  its  capital  stock  and  does  not  anticipate  paying  cash  dividends  in  the  foreseeable  future.  By
agreement,  we  have  to  issue  dividend  in  preferred  stock  to  preferred  stock  holders,  cash  dividend  to  preferred  stock  holders  is  not  anticipated  in  the  foreseeable
future. The Company’s current policy is to retain any earnings in order to finance the expansion of its operations. The Company’s Board of Directors will determine
future declaration and payment of dividends, if any, in light of the then-current conditions they deem relevant and in accordance with the Nevada Revised Statutes.

10

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Recent Sales of Unregistered Securities

On  January 24, 2007, the  Company entered into a merger agreement and plan of reorganization with  Celsius,  Inc.,  Elite and  Stephen  C.  Haley, the "Indemnifying
Officer”  and  "Securityholder Agent”  of  Elite  pursuant  to  which  Elite  was  merged  into  Celsius,  Inc.  and  became  a  wholly-owned  subsidiary  of  the  Company  on
January 26, 2007 (the "Merger”).

Under the terms of the Merger Agreement, the Company issued:

·  70,912,246 shares of its Common Stock to the stockholders of Elite as full consideration for the shares of Elite;

·  1,391,500 shares  of  its  Common  Stock  and  a  promissory  note  in  the  amount  of  $250,000 to  Specialty  Nutrition  Group,  Inc.  ("SNG”)  as  consideration  for
termination  of  a  consulting  agreement  and  assignment  of  certain  trademark rights  to  the  name  "Celsius”.  The  note  is  non-interest  bearing  and requires  the
Company to pay SNG $15,000 a month for eight (8) months starting March 30, 2007 and a lump sum payment of $130,000 on November 30, 2007.

These shares of our Common Stock and the note qualified for exemption under Section 4(2) of the Securities Act of 1933 (the "Securities Act”) since the issuance
shares by us did not involve a public offering. The offerings were not "public offerings” as defined in Section 4(2) due to the insubstantial number of persons involved
in the deal, size of the offering, and manner of the offering and number of shares offered. We did not undertake an offering in which we sold a high number of shares
or notes to a high number of investors. In addition, these stockholders and the note holder had and agreed to the necessary investment intent as required by Section
4(2).  Based  on  an  analysis  of  the  above  factors,  we  have  met  the  requirements  to  qualify  for  exemption  under  Section  4(2)  of  the  Securities  Act  for  these
transactions.

In addition, under the terms of the Merger Agreement, the Company issued:

·  warrants to Investa Capital Partners Inc. representing 3,557,812 shares of Common Stock of the Company which were exercised by on February 9, 2007 for

an aggregate consideration of $500,000 in cash.

·  1,300,000 shares  of  its  Common  Stock  concurrent  with  the  Merger  in  a  private placement  to  non-US  resident  investors  for  aggregate  consideration  of

US$650,000 which included the conversion of a $250,000 loan to the Company

On November 8, 2006, the Company issued a promissory note in the principal amount of US$250,000 to Barca Business Services ("Barca”).  Prior to the execution of
the Note, there was no relationship between the Company and Barca. The Note bore interest at an annual rate of eight percent (8%) per annum and was due and
payable  in  full  one  year  from  the  date  of  issuance.  The  note  was  converted  into  500,000  shares  of  its  Common  Stock  as  part  of  a  private  placement  conducted
concurrent with the close of the Merger Agreement.

On February 23, 2007 the Company issued 3,557,812 shares of Common Stock to Investa Capital Partners Inc. for an aggregate consideration of $500,000 in cash
representing their exercise of the warrant issued under the terms of the Merger Agreement.

On April 2, 2007 we issued a promissory note to Brennecke Partners, LLC for $250,000. The note was due on demand and carried interest of 9 percent per annum.

11

 
 
 
 
 
 
 
 
 
 
 
 
 
On May 15, and June 2, 2007, the Company issued 30,000 and 50,000 shares of Common Stock, respectively to RedChip Companies as consideration for investor
relations services. The shares were valued at $70,500 based on the then current market price.

On June 15, 2007, the Company issued 25,000 shares of Common Stock to Fusion Capital, LLC as non-allocable expense reimbursement to cover such items as travel
expenses and other expenses in connection with their due diligence of a finance transaction with the Company.

On June 22 and July 16, 2007 the Company issued a total of 3,168,305 for a total consideration of $1.0 million as part of the Purchase Agreement with Fusion Capital,
LLC.

MidSouth Capital, Inc. received, as placement agent for the Fusion Capital financing, a warrant to purchase 75,000 shares at a price of $1.31 per share. The warrant
expires June 22, 2012.

In September and October, 2007 the Company issued a total of 250,000 unregistered shares to four parties for a total consideration of $100,000 as part of a private
placement.

On October 1, 2007, the Company issued 30,000 unregistered shares as consideration for a trademark agreement. The shares were valued at $16,500 based on the
then current market price.

On October 25, 2007, the Company issued 100,000 unregistered shares as consideration for a licensing agreement. The shares were valued at $53,000 based on the
then current market price.

On December 18, 2007 the Company received a $250,000 convertible loan from CD Financial LLC. The loan incurs eight percent interest per annum, and the note
was  due  on April  16,  2008.  On April  4,  2008,  the  company  received  an  additional  $500,000  from  CD  Financial,  LLC  on  the  same  terms,  as  the  first  note,  also
extending the due date of the first note. The notes were converted into 11,184,016 shares of common stock on June 10, 2008.

On December 19, 2007, the Company entered into a $6 million security purchase agreement (the "Security Agreement”) with Golden Gate Investors, Inc ("GGI”), a
California corporation. Under the Security Agreement, the Company issued as a first tranche a $1.5 million convertible debenture maturing on December 19, 2011.
The debenture accrues seven and 3/4 percent interest per annum.  As consideration the Company received $250,000 in cash and a note receivable for $1,250,000.
The note receivable accrues eight percent interest per annum and is due on December 19, 2012. The note has a pre-payment obligation of $250,000 per month when
certain criteria are fulfilled. The debenture is convertible to common shares at a conversion rate of eighty percent of the average of the three lowest volume weighted
average  prices  for  the  previous  20  trading  days. As  of  December  31,  2008,  GGI  had  converted  $799,000  of  the  convertible  debenture  for  16,846,645  shares  of
Common Stock.

On January 22, 2008 the Company issued 1,000,000 unregistered common stock and a note for $105,000 to Brennecke Partners, LLC in exchange for the note issued
on April 7, 2007 and accrued interest having an aggregate value of $225,155.

On February 15, 2008 the Company issued 16,671 unregistered shares of common stock in accordance to its 2006 Stock Incentive Plan to an employee exercising
vested options.

In February, 2008 the Company issued a total of 3,198,529 unregistered shares of common stock in private placements for an aggregate consideration of $298,900, net
of commissions.

In  March,  2008  the  Company  issued  a  total  of  750,000  unregistered  shares  of  common  stock  as  compensation  to  an  international  distributor  for  an  aggregate
consideration of $120,000.

12

 
 
 
 
 
 
 
 
 
 
 
 
 
 
In March, 2008 the Company issued a total of 10,000,000 unregistered shares of common stock in a private placement, for an aggregate consideration of $500,100. In
addition, the investor received a warrant to purchase seven million unregistered shares of common stock during a 3-year period, at an exercise price of $0.13 per
share. Of the total consideration, $100,000 was paid in March 2008 and the remaining $400,100 was paid on April 7, 2008.

In  June 2008 the  Company issued 11.2 million unregistered shares as conversion for a $750,000 convertible note that was originally issued in  December 2007 and
April 2008.

In June through December 2008, the Company issued 16.8 million shares of common stock as partial conversion of a convertible debenture issued in December 2007.

In June and July 2008, the Company issued two convertible notes of $250,000, each.  In August 2008, the Company issued 2,000 unregistered Series A Preferred
Shares, and a warrant to purchase an additional 1,000 shares of Series A Preferred Shares at the same price for a cash payment of $1.5 million and the cancellation
of two notes in aggregate amount of $500,000.

In September, 2008, the Company granted 25,000 shares to a distributor, with a value of $1,450, as compensation for purchases of products from the Company.

From September to December, 2008, the Company granted 158,135 unregistered shares to a consultant, with a value of $10,000, as compensation for services to the
Company.

In December 2008, the Company issued 2,000 unregistered Series B Preferred Shares, and a warrant to purchase an additional 2,000 Series B Preferred Shares at
the same price for an aggregate consideration of $2.0 million in cash.

The Company believes that all of the foregoing sales qualified for exemption under Section 4(2) of the Securities Act since the issuance of the notes and shares by us
did not involve a public offering. The offerings were not "public offerings” as defined in Section 4(2) due to the insubstantial number of persons involved in the deal,
size of the offering, and manner of the offering and number of shares offered. We did not undertake an offering in which we sold a high number of shares or notes to
a high number of investors. In addition, these stockholders and note holders had and agreed to the necessary investment intent as required by Section 4(2). Based on
an analysis of the above factors, we have met the requirements to qualify for exemption under  Section 4(2) of the  Securities Act of 1933, as amended, for these
transactions.

We did not employ an underwriter in connection with the issuance of the securities described above.

ITEM 6             MANAGEMENT’S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION

General

The following is a discussion of the financial condition and results of operations of Celsius Holdings, Inc. comparing the twelve months ended December 31, 2008
compared  to  the  twelve  months  ended  December  31,  2007,  and  comparing  the  twelve  months  ended  December  31,  2007  compared  to  the  twelve  months  ended
December 31, 2006. We operate in the United States through our wholly-owned subsidiaries Celsius Netshipments, Inc. and Celsius Inc, which acquired the operating
business of Elite FX, Inc. through a reverse merger on January 26, 2007. You should read this section together with the Company’s financial statements included in
Form 10-K, including the notes to those financial statements, for the years mentioned above. Dollar amounts of $1.0 million or more are rounded to the nearest one
tenth of a million; all other dollar amounts are rounded to the nearest one thousand and all percentages are stated to the nearest one tenth of one percent.

13

 
 
 
 
 
 
 
 
 
 
 
 
 
Overview

We are in the business of producing, distributing and marketing bottled drinks in the functional beverage category of the soft drink industry. Celsius® was our first
commercially available product. Celsius is a calorie burning soda. Celsius is currently available in five sparkling flavors: cola, ginger ale, lemon/lime, orange and wild
berry, and two non-carbonated green tea flavors: peach/mango and raspberry/acai.

We started our business toward the end of 2004. We had our first revenue in 2005 and have increased the number of distributor and stores that carry our products
rapidly over the last three years. We had approximately thirty-five active distributors each of the last three years, however, the distributors were changed over time
and we have now a better distributor network compared to before. We are also selling directly to various retail store chains with increasing success.

We are using Celsius as a means to attract and sign up DSD (direct store delivery) distributors across the US. Once we have a comprehensive network in place we
plan on launching additional brands through that network.

DSD distributors are wholesalers/distributors that will purchase product, store it in their warehouse and then using their own trucks sell and deliver the product direct
to retailers and their store shelves or cooler doors. During this process they will make sure that the product is properly placed on the shelves, manage the invoicing
and collection process and train local personnel. Most retailers prefer this method to get beverages to their stores. There are some retailers that prefer a different
method  called  Direct  to  Retailer  (DTR).  In  this  scenario,  the  retailer  is  buying  direct  from  the  brand  manufacturer  and  the  product  is  delivered  to  the  retailer’s
warehousing system. The retailer is then responsible to properly stock the product and get it to the shelves. Our strategy is to cover the country with a network of
DSD distributors. This allows us to sell to retailer chains that prefer this method and whose store locations span across distributor boundaries. Also, and maybe more
importantly,  a  strong  DSD  network  gives  us  a  path  to  get  to  the  smaller  independent  retailers  who  are  too  small  to  have  their  own  warehousing  and  distribution
systems and thus can only get their beverages from distributors. Our strategy of building a DSD network will not prohibit us from going DTR when a retailer requests
or requires it.

We have currently signed up distributors in many of the larger markets in the US (Chicago, Detroit, Boston, Tampa, South East Florida, Los Angeles, etc). We expect
that it will take at least until the end of 2009 before we have most of the US covered.

Our experience has shown that it takes about two to three months to bring on a DSD distributor. From initial interest to actual purchase order and kick off or the
launch in that area, the steps include several meetings to explain the brand, target markets and our marketing plans. As we add sales reps we are able to do more of
these activities at a time and speed up the process.

Our  principal  executive  offices  are  located  at  140  NE  4th  Avenue,  Delray  Beach,  FL  33483.  Our  telephone  number  is  (561)  276-2239  and  our  website  is
http://www.celsius.com. The information contained on our website does not constitute part of, nor is it incorporated by reference into, this Form 10-K annual report.

14

 
 
 
 
 
 
 
 
 
Forward-Looking Statements

Information  included  or  incorporated  by  reference  in  this  10-K  may  contain  forward-looking  statements.  This  information  may  involve  known  and  unknown  risks,
uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from the future results, performance or
achievements  expressed  or  implied  by  any  forward-looking  statements.  Forward-looking  statements,  which  involve  assumptions  and  describe  our  future  plans,
strategies and expectations, are generally identifiable by use of the words "may”, "should”, "expect”, "anticipate”, "estimate”, "believe”, "intend” or "project” or the
negative of these words or other variations on these words or comparable terminology.

This 10-K contains forward-looking statements, including statements regarding, among other things, (a) our projected sales and profitability, (b) our growth strategies,
(c)  anticipated  trends  in  our  industry,  (d)  our  future  financing  plans  and  (e)  our  anticipated  needs  for  working  capital.  These  statements  may  be  found  under
"Management’s Discussion and Analysis or Plan of Operations” and "Description of Business” Actual events or results may differ materially from those discussed in
forward-looking statements as a result of various factors, including, without limitation, the risks outlined under "Risk Factors” and matters described in this Form 10-K
generally. In light of these risks and uncertainties, there can be no assurance that the forward-looking statements contained in this Form 10-K will in fact occur.

Accounting Policies and Pronouncements

Critical Accounting Policies

The  discussion  and  analysis  of  our  financial  condition  and  results  of  operations  is  based  upon  our  consolidated  financial  statements,  which  have  been  prepared  in
accordance with Generally Accepted Accounting Principles (GAAP). The preparation of these financial statements requires us to make estimates and judgments that
affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate
our estimates including, among others, those affecting revenues, the allowance for doubtful accounts, the salability of inventory and the useful lives of tangible and
intangible assets.  We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the
results of which form our basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results
may differ from these estimates under different assumptions or conditions, or if management made different judgments or utilized different estimates. Many of our
estimates  or  judgments  are  based  on  anticipated  future  events  or  performance,  and  as  such  are  forward-looking  in  nature,  and  are  subject  to  many  risks  and
uncertainties, including those discussed below and elsewhere in this report. We do not undertake any obligation to update or revise this discussion to reflect any future
events or circumstances.

Although our significant accounting policies are described in Note 2 of the notes to consolidated financial statement, the following discussion is intended to describe
those accounting policies and estimates most critical to the preparation of our consolidated financial statements. For a detailed discussion on the application of these
and our other accounting policies, see Note 2 contained in Part II, Item 7 to the Consolidated Financial Statements for the year ended December 31, 2008.

15

 
 
 
 
 
 
 
 
Accounts Receivable – We evaluate the collectability of its trade accounts receivable based on a number of factors. In circumstances where we become aware of a
specific customer’s inability to meet its financial obligations, a specific reserve for bad debts is estimated and recorded, which reduces the recognized receivable to
the estimated amount we believe will ultimately be collected.   In addition to specific customer identification of potential bad debts, bad debt charges are recorded
based on our recent past loss history and an overall assessment of past due trade accounts receivable outstanding.

Revenue  Recognition –  Our  products  are  sold  to  distributors,  wholesalers  and  retailers  for  cash  or  on  credit  terms.  Our  credit  terms,  which  are  established  in
accordance  with  local  and  industry  practices,  typically  require  payment  within  30  days  of  delivery.  We  recognize  revenue  when  persuasive  evidence  of  an
arrangement exists, delivery has occurred, the sales price is fixed or determinable and collectability is reasonably assured.   All sales to distributors and retailers are
final sales and we have a "no return” policy; however, in limited instances, due to credit issues or distributor changes, we may take back product. We believe that
adequate provision has been made for cash discounts, returns, customer incentives and spoilage based on the Company’s historical experience. Revenue recognized is
reduced by any cash discounts, returns and customer incentives related to the revenue originally recognized for the sale of the product.

Inventory – We hold raw materials and finished goods inventories, which are manufactured and procured based on our sales forecasts. We value inventory at the
lower  of  cost  and  estimated  net  realizable  value  and  include  adjustments  for  estimated  obsolescence,  principally  on  a  first  in-first  out  basis.  These  valuations  are
subject to customer acceptance and demand for the particular products, and our estimates of future realizable values are based on these forecasted demands. We
regularly review inventory detail to determine whether a write-down is necessary. We consider various factors in making this determination, including recent sales
history and predicted trends, industry market conditions and general economic conditions. Differences could result in the amount and timing of write-downs for any
period if we make different judgments or use different estimates.

Intangibles  –  Intangibles  are  comprised  primarily  of  trademarks  that  represent  our  exclusive  ownership  of  the  Celsius®  trademark  in  connection  with  the
manufacture,  sale  and  distribution  of  supplements  and  beverages.    The  Company  also  owns,  or  is  in  process  of  registering,  some  other  trademarks  in  the  United
States, as well as in a number of countries around the world. 

In accordance with SFAS No. 142, we evaluate our trademarks annually for impairment or earlier if there is an indication of impairment.  If there is an indication of
impairment  of  identified  intangible  assets  not  subject  to  amortization,  management  compares  the  estimated  fair  value  with  the  carrying  amount  of  the  asset.   An
impairment loss is recognized to write down the intangible asset to its fair value if it is less than the carrying amount.  The fair value is calculated using the income
approach.    However,  preparation  of  estimated  expected  future  cash  flows  is  inherently  subjective  and  is  based  on  management’s  best  estimate  of  assumptions
concerning expected future conditions.  Based on management’s impairment analysis performed for the year ended December 31, 2008, the estimated fair values of
trademarks exceeded the carrying value.

In estimating future revenues, we use internal budgets.  Internal budgets are developed based on recent revenue data and future marketing plans for existing product
lines and planned timing of future introductions of new products and their impact on our future cash flows.

16

 
 
 
 
 
 
 
Stock-Based Compensation –We use the Black-Scholes-Merton option pricing formula to estimate the fair value of its stock options at the date of grant. The Black-
Scholes-Merton option pricing formula was developed for use in estimating the fair value of traded options that have no vesting restrictions and are fully transferable.
The Company’s employee stock options, however, have characteristics significantly different from those of traded options. For example, employee stock options are
generally  subject  to  vesting  restrictions  and  are  generally  not  transferable.  In  addition,  option  valuation  models  require  the  input  of  highly  subjective  assumptions,
including  the  expected  stock  price  volatility,  the  expected  life  of  an  option  and  the  number  of  awards  ultimately  expected  to  vest.  Changes  in  subjective  input
assumptions can materially affect the fair value estimates of an option. Furthermore, the estimated fair value of an option does not necessarily represent the value that
will  ultimately  be  realized  by  an  employee.  The  Company  uses  historical  data  to  estimate  the  expected  price  volatility,  the  expected  option  life  and  the  expected
forfeiture rate. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the estimated life of the option. If actual results are not
consistent  with  the  Company’s  assumptions  and  judgments  used  in  estimating  the  key  assumptions,  the  Company  may  be  required  to  increase  or  decrease
compensation expense or income tax expense, which could be material to its results of operations.

Newly Issued Accounting Pronouncements

Information regarding newly issued accounting pronouncements is contained in Part II, Item 7, Note 2 to the Consolidated Financial Statements for the year ended
December 31, 2008.

Results of Operations for the Year Ended December 31, 2008 Compared to the Year Ended December 31, 2007

Revenue

Revenue increased 57.5 percent for the year 2008 to $2.6 million, as compared to $1.6 million in 2007. The increase was mainly due to increased number of retailers
selling  our  product,  such  as  Walgreens,  CVS,  Meijers;  new  large  distributors  such  as  Farner-Bocken,  Polar  Beverages  and  RSI;  increases  from  our  existing
customers such as Vitamin Shoppe and Krogers; and to a large export order in the second quarter of the year, offset to a lesser extent by losses of some accounts.

Gross Profit

Gross profit was 29.2 percent of net revenue during the year 2008, as compared to 37.1 percent in 2007. The decrease is mainly due to the decision to discontinue
sales of Celsius in glass bottles and solely concentrate on cans. We recorded a write down of inventory due to obsolescence of bottled finished goods and packaging
material of $320,000 in 2008. No such write down occurred in 2007. Without this write down our gross profit would have been 41.6 percent in 2008.

Operating Expenses

Sales and marketing expenses increased to $3.9 million in 2008 as compared to $2.1 million in 2007, an increase of $1.8 million or 87.4 percent. This increase was
mainly due to increased cost for personnel, $372,000; new local distribution organization in South Florida, $225,000; increased cost of sampling events and other local
promotion,  $882,000;  license  rights  to  the  song  "Burn  Baby  Burn”  and  radio  advertising  increase,  $344,000.  We  have  shifted  our  focus  on  sales  and  marketing
expenditure. General and administrative expenses increased to $1.7 million in 2008 as compared to $1.6 million in 2007, an increase of $186,000. The increase was
mainly due to increased cost for issuance of shares to third parties for services, $86,000; increased product development expenses, $48,000; increased collection and
factoring expenses, $74,000; offset to a lesser extent by decreased investor relations expenses, $63,000; and decreased insurance expenses, $59,000.

17

 
 
 
 
 
 
 
 
 
 
 
We recognized an expense for termination of a consulting agreement in the first quarter of 2007 of $500,000. Coinciding with the Merger, the Company issued 1.4
million shares of Common Stock, valued at $250,000, and an interest-free note for $250,000, as consideration for termination of a consulting agreement.

Other Expense

Other  expense  consists  of  interest  on  outstanding  loans  of  $412,000  in  2008  as  compared  to  $189,000  in  2007.  The  increase  of  $223,000  was  mainly  due  to
amortization of debt discounts on convertible notes for a total of $211,000, increased interest cost on a convertible debenture of $93,000, offset to a lesser extent by
decreased loan balances and renegotiation of interest rates. Our interest income increased from $8,000 in 2007 to $70,000 in 2008, an increase of $62,000, due to a
note receivable from Golden Gate Investors, Inc.

Liquidity and Capital Resources

We have yet to establish any history of profitable operations.  We have incurred annual operating losses of $5.3 million, $3.7 million and $1.5 million, respectively,
during the past three years of operation, 2008, 2007 and 2006, respectively. As a result, at December 31, 2008, we had an accumulated deficit of $11.4 million. At
December  31,  2008,  we  had  a  working  capital  of  $897,000.  The  independent  auditor’s  report  for  the  year  ended  December  31,  2008,  includes  an  explanatory
paragraph  to  their  audit  opinion  stating  that  our  recurring  losses  from  operations  raise  substantial  doubt  about  our  ability  to  continue  as  a  going  concern.  We  had
operating  cash  flow  deficits  of  $4.8  million,  $2.6  million  and  $1.2  million,  for  last  three  years,  respectively.  Our  revenue  has  not  been  sufficient  to  sustain  our
operations.  We  expect  that  our  revenue  will  not  be  sufficient  to  sustain  our  operations  for  the  foreseeable  future.  Our  profitability  will  require  the  successful
commercialization of our current product Celsius® and any future products we develop.  No assurances can be given when this will occur or that we will ever be
profitable.

We fund part of our working capital from a line of credit with a major investor in our company. We entered into this agreement in December 2008. The line of credit
is for $1.0 million, with interest at LIBOR plus 3 percentage points. The line expires in December 2009 and is renewable. There was no outstanding balance as of
December 31, 2008. In connection with the revolving line of credit we have entered into a loan and security agreement under which we have pledged all our assets as
security for the line of credit.

We previously had two lines of credit with a factoring company and inventory finance company. Both lines were paid off in the fourth quarter of 2008.

In April 2007, the Company received $250,000 in bridge financing from Brennecke Partners LLC. The loan is due on demand and carries interest of nine percent per
year.  In  January 2008, we renegotiated the note converting the balance for one million shares in the  Company and a new non-interest bearing note for $105,000,
payable in 7 monthly installments starting March 1, 2008. There was no outstanding balance on the note as of December 31, 2008.

We borrowed in 2004 and 2005 a total of $500,000 from one of our stockholders with interest of a rate variable with the prime rate. In July 2008, we restructured the
agreement and decreased the interest rate to prime rate flat, no collateral, monthly payments of $5,000 until a balloon payment of approximately $606,000 in January
2010. The outstanding balance as of December 31, 2008 was $644,000.

18

 
 
 
 
 
 
 
 
 
 
We borrowed $50,000 from the CEO of the Company in February 2006. We also owed the CEO $171,000 for accrued salaries from 2006 and 2007. The two debts
were  restructured  into  one  note  accruing  3%  interest,  no  collateral,  monthly  payments  of  $5,000  and  with  a  balloon  payment  of  $64,000  in  January  2011.  The
outstanding balance as of December 31, 2008 was $176,000.

We  terminated  a  consulting  agreement  with  a  company  controlled  by  one  of  our  directors. As  partial  consideration  we  issued  a  note  payable  for  $250,000.  The
outstanding balance as of December 31, 2008 was $95,000.

We entered into a Stock Purchase Agreement with Fusion Capital in June 2007. During 2007, we received $1.4 million in proceeds from sales of shares to Fusion
Capital. We can sell shares for a consideration of up to $14.6 million to Fusion Capital until October 2009, when and if the selling price of the shares to Fusion Capital
exceeds $0.45. See Our Purchase Agreement with Fusion Capital below.

We received during 2007 a total of $400,000 as deposits against future orders from an international customer. We received a purchase order from the customer, and
shipped products in April and June of 2008 offsetting the deposit.

We issued in December 2007 a convertible note for $1.5 million and received $250,000 in cash and a note receivable for $1.3 million. See Our Purchase Agreement
with Golden Gate Investors, Inc. below.

We issued in December 2007, a convertible note to CD Financial LLC ("CD”) for $250,000. The note carried 8 percent interest and was due on April 16, 2008. The
note was refinanced in April at the time CD lent us additional $500,000. The combined note was converted in June 2008 to 11.2 million shares.

We issued in June and July, 2008, two separate convertible notes to CD, each for $250,000. The notes carried 8 percent interest. In August of 2008, we entered into a
security purchase agreement with CDS Ventures of South Florida, LLC ("CDS”), an affiliate of CD, pursuant to which we received $1.5 million in cash, cancelled the
two  convertible  notes  issued  to  CD  Financial,  LLC  and  issued  2,000  Series A  Preferred  Shares,  and  a  warrant  to  purchase  additional  1,000  Series A  Preferred
Shares. See Our Security Purchase Agreement with CDS Ventures of South Florida, LLC below.

In November and December 2008, we received loans from CD in the amount of $450,000 and $200,000, respectively. These loans incurred 10% interest per annum
and were paid off in December 2008.

In December of 2008, we entered into a second security purchase agreement with CDS, pursuant to which we received $2.0 million in cash and issued 2,000 Series B
Preferred  Shares,  and  a  warrant  to  purchase  additional  2,000  Series  B  Preferred  Shares  at  the  same  price.  See  Our  Security  Purchase  Agreement  with  CDS
Ventures of South Florida, LLC below.

We will require additional financing to sustain our operations. Management estimates that we need to raise an additional $2.0 to $3.0 million in order to implement our
revised business plan over the next 12 months. We have already negotiated to receive additional $2.0 million in financing from CDS during 2009. We do not currently
have sufficient financial resources to fund our operations or those of our subsidiaries.  Therefore, we need additional funds to continue these operations.  We need
approval from CDS before we acquire any additional debt. No assurances can be given that the Company will be able to raise sufficient financing.

19

 
 
 
 
 
 
 
 
 
 
 
The following table summarizes contractual obligations and borrowings as of December 31, 2008, and the timing and effect that such commitments are expected to
have on our liquidity and capital requirements in future periods (in thousands). We expect to fund these commitments primarily with raising of debt or equity capital.

Contractual 
Obligations

Debt to related party
Loans payable
Convertible debenture
Purchase obligations

Total

Payments Due by Period

Total

Less Than
1 Year

1 to
3 Years

3 to
5 Years

More Than
5 Years

820 
196 
563 
— 
1,579 

$

$

120 
121 
563 
— 
804 

700 
58 
— 
— 
758 

$

— 
17 
— 
— 
17 

$

$

—
—
—
—
—

Our Purchase Agreement with Fusion Capital

On  June  22,  2007,  we  signed  a  $16  million  common  stock  purchase  agreement  (the  "Purchase Agreement”)  with  Fusion  Capital  Fund  II,  LLC,  an  Illinois  limited
liability  company  ("Fusion  Capital”).  We  received  $500,000  from  Fusion  Capital  at  the  time  of  signing  the  agreement  and  $500,000  when  we  filed  a  registration
statement, in exchange for 3,168,305 shares of common stock. After the  SEC declared effective the registration statement related to the transaction, we received
additionally $400,000 in October of 2007 in exchange for 795,495 shares of common stock. We have the right over a twenty-five (25) month period to sell shares of
Common  Stock  to  Fusion  Capital  from  time  to  time  in  amounts  between  $100,000  and  $1  million,  depending  on  certain  conditions  as  set  forth  in  the  Purchase
Agreement, up to an additional $14.6 million.

The purchase price of the shares related to the $14.6 million of future funding will be based on the prevailing market prices of the Company’s shares at the time of
sales without any fixed discount, and the Company will control the timing and amount of any sales of shares to Fusion Capital. Fusion Capital shall not have the right
or the obligation to purchase any shares of our Common Stock on any business day that the price of our Common Stock is below $0.45. The Purchase Agreement
may be terminated by us at any time at our discretion without any cost to us. The proceeds received by the Company under the Purchase Agreement will be used for
marketing expenses towards building the Celsius brand, working capital and general corporate use.

The foregoing description of the  Purchase Agreement and the  Registration Agreement are qualified in their entirety by reference to the full text of the  Purchase
Agreement and the Registration Rights Agreement, a copy of each of which was filed as Exhibit 10.1 and 10.2, respectively to our Current Report on Form 8-K as
filed with the SEC on June 25, 2007 and each of which is incorporated herein in its entirety by reference.

20

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Our Purchase Agreement with Golden Gate Investors, Inc.

On  December  19,  2007,  we  entered  into  a  securities  purchase  agreement  with  Golden  Gate  Investors,  Inc  ("GGI”).  The  agreement  includes  four  tranches  of
$1,500,000  each.    Each  tranche  consists  of  a  7.75%  convertible  debenture  (the  "Debenture”)  issued  by  the  Company,  in  exchange  for  $250,000  in  cash  and  a
promissory note for $1,250,000 issued by GGI which matures on February 1, 2012. The promissory note contains a prepayment provision which requires GGI to make
prepayments  of  interest  and  principal  of  $250,000  monthly  upon  satisfaction  of  certain  conditions.  One  of  the  conditions  to  prepayment  is  that  Company’s  shares
issued pursuant to the conversion rights under Debenture must be freely tradable under Rule 144 of the Securities Act of 1933. The Debenture can be converted at
any time with a conversion price as the lower of (i) $1.00, or (ii) 80% of the average of the three lowest daily volume weighted average price during the 20 trading
days prior to GGI’s election to convert. The Company is not required to issue the shares unless a corresponding payment has been made on the promissory note.

Tranches 2, 3 and 4 can be consummated at the election of GGI at any time beginning upon the execution of the Debenture, or successive debenture, until the balance
due under the Debenture, or each successive debenture, decreases below $250,000. Tranches 2, 3 and 4 of the agreement with Golden Gate Investors, Inc. may be
rescinded and not effectuated by either party, subject to payment of a penalty.

The foregoing description is qualified in their entirety by reference to the full text of the promissory note, purchase agreement, and  Debenture, a copy of each of
which was filed as Exhibit 10.2, 10.3, and 10.4 respectively to our Current Report on Form 8-K/A as filed with the SEC on January 9, 2008 and each of which is
incorporated herein in its entirety by reference.

Our Security Purchase Agreements with CDS Ventures of South Florida, LLC

On August  8,  2008,  we  entered  into  a  securities  purchase  agreement  ("SPA1”)  with  CDS,  an  affiliate  of  CD  Financial,  LLC  ("CD”).  Pursuant  to  the  SPA1,  we
issued 2,000 Series A preferred shares ("Preferred A Shares”), as well as a warrant to purchase additional 1,000 Preferred A Shares, for a cash payment of $1.5
million and the cancellation of two notes in aggregate amount of $500,000 issued to CD. The Preferred A Shares can be converted into our common stock at any
time; until December 31, 2010, (as amended on December 12, 2008), the conversion price is $0.08, after which the conversion price is the greater of $0.08 or 90% of
the volume weighted average price of the common stock for the prior 10 trading days.  Pursuant to the  SPA, we also entered into a registration rights agreement,
under  which  we  agreed  to  file  a  registration  statement  for  the  common  stock  issuable  upon  conversion  of  Preferred  Shares.  We  have  filed  this  registration
statement.  The Preferred A Shares accrues ten percent annual cumulative dividend, payable in additional Preferred A Shares. The Preferred A Shares mature on
February 1, 2013 and are redeemable only in  Company  Common  Stock.  The full agreement can be reviewed in the  Company’s  Form 8-K filed with the  SEC on
August 12, 2008.

On  December 12, 2008, we entered into a securities purchase agreement ("SPA2”) with  CDS.  Pursuant to the  SPA2 we issued 2,000  Series  B preferred shares
("Preferred B Shares”), as well as a warrant to purchase additional 2,000 Preferred B Shares, for a cash payment of $2.0 million. The Preferred B Shares can be
converted into our common stock at any time.  Until December 31, 2010, the conversion price is $0.05, after which the conversion price is the greater of $0.05 or
90% of the volume weighted average price of the common stock for the prior 10 trading days. Pursuant to the SPA2, we entered into a registration rights agreement
under which we agreed to file a registration statement for the common stock issuable upon conversion of Preferred B Shares. The Preferred B Shares accrue a ten
percent annual cumulative dividend, payable in additional Preferred  B  Shares.  The  Preferred  B  Shares mature on  December 31, 2013 and are redeemable only in
Company Common Stock. The full agreement can be reviewed in the Company’s Form 8-K filed with the SEC on December 17, 2008.

21

 
 
 
 
 
 
 
 
Certain covenants of both  Series A and  B preferred shares restrict the  Company to enter into additional debt or to permit liens to be filed against the  Company’s
assets,  without  approval  from  the  holder  of  the  preferred  shares.  There  is  a  mandatory  redemption  in  cash,  if  the  Company  breaches  certain  covenants  of  the
agreements. The holders have liquidation preference in case of company liquidation. The Company has the right to redeem the preferred shares early in cash at 104%
of the liquidation preference value for Series A, any date after July 1, 2010 and for Series B, any date after January 1, 2011.

Related Party Transactions

We received advances from one of our stockholders at various instances during 2004 and 2005, $76,000 and $424,000, respectively. In July 2008, we restructured the
agreement and decreased the interest rate to prime rate flat, no collateral, monthly payments of $5,000 until a balloon payment of approximately $606,000 in January
2010. The outstanding balance as of December 31, 2008 was $644,000.

We have accrued $171,000 for the CEO’s salary from March 2006 through  May 30, 2007.  The  CEO also lent us $50,000 in  February 2006.  The two debts were
restructured  into  one  note  accruing  3  percent  interest,  no  collateral,  monthly  payments  of  $5,000  and  with  a  balloon  payment  of  $64,000  in  January  2011.  The
outstanding balance as of December 31, 2008 was $176,000.

The CEO has guaranteed the Company’s obligations under the factoring agreement with Bibby Financial Services, Inc. ("Bibby”). This agreement has been cancelled
and the debt was paid off in November 2008. The CEO has also guaranteed the financing of vehicles on our behalf, and was previously guaranteeing the office lease
for the Company. The CEO was not compensated for issuing the guarantees.

The COO of the Company lent us $50,000 in February 2008; the loan was repaid in March 2008. The COO also purchased in February 2008, 781,250 shares in a
private placement for a total consideration of $75,000.

The CFO of the Company lent us $25,000 in February 2008; the loan was repaid in February 2008. The CFO also purchased in February 2008, 245,098 shares in a
private placement for a total consideration of $25,000.

In February 2008, the VP of Strategic Accounts and Business Development purchased 245,098 shares in a private placement for a total consideration of $25,000.

Related party transactions are contracted on terms comparable to the terms of similar transactions with unaffiliated parties.

Going Concern

The  accompanying  consolidated  financial  statements  are  presented  on  a  going  concern  basis.  The  Company  has  suffered  losses  from  operations,  and  has  an
accumulated deficit and net cash used in operations of $4,840,152 for the year ended December 31, 2008. This raises substantial doubt about its ability to continue as
a going concern. Management is currently seeking new capital or debt financing to provide funds needed to increase liquidity, fund growth, and implement its business
plan. However, no assurances can be given that the Company will be able to raise any additional funds. If not successful in obtaining financing, the Company will
have to substantially diminish or cease its operations. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

22

 
 
 
 
 
 
 
 
 
 
 
 
ITEM 7.            CONSOLIDATED FINANCIAL STATEMENTS

Celsius Holdings, Inc. and Subsidiaries

Report of Independent Registered Public Accounting Firm

Consolidated Balance Sheets as of December 31, 2008 and 2007

Consolidated Statements of Operations for the years ended December 31, 2008 and 2007

Consolidated Statements of Changes in Stockholders' Equity(Deficit) for the years ended December 31, 2008 and 2007

Consolidated Statements of Cash Flows for the years ended December 31, 2008 and 2007

Notes to Consolidated Financial Statements   

24

25

26

27

28

29-46

23

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1900 NW Corporate Blvd., Suite 210 East
Boca Raton, Florida 33431
Tel. 561-886-4200
Fax. 561-886-3330
 e-mail:info@sherbcpa.com

 Offices in New York and Florida

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

  SHERB & CO., LLP

Certified Public Accountants

To the Board of Directors
Celsius Holdings, Inc.

We have audited the accompanying consolidated balance sheets of Celsius Holdings, Inc. and Subsidiaries as of December 31, 2008 and 2007, respectively, and the
related consolidated statements of operations, changes in stockholders' equity (deficit) and cash flows for the years ended December 31, 2008 and 2007, respectively.
These consolidated financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements
based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan
and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to  have,
nor  were  we  engaged  to  perform,  an  audit  of  its  internal  control  over  financial  reporting  as  a  basis  for  designing  audit  procedures  that  are  appropriate  in  the
circumstances,  but  not  for  the  purpose  of  expressing  an  opinion  on  the    effectiveness  of  the  Company's  internal  control  over  financial  reporting. Accordingly  we
express  no  such  opinion. An  audit  includes  examining,  on  a  test  basis,  evidence  supporting  the  amounts  and  disclosures  in  the  financial  statements. An  audit  also
includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statements presentation.
We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company and subsidiaries as
of December 31, 2008 and 2007, respectively, and the results of their operations and cash flows for the years ended December 31, 2008, and 2007, respectively, in
conformity with accounting principles generally accepted in the United States of America.

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the
consolidated financial statements, the Company has suffered losses from operations, and has an accumulated deficit and net cash used in operations of $4,840,152 for
the year ended December 31, 2008. This raises substantial doubt about its ability to continue as a going concern. Management's plans in regards to these matters are
described in Note 2 to the consolidated financial statements. The consolidated financial statements do not include any adjustments that might result from the outcome
of this uncertainty.

Boca Raton, Florida
February 23, 2009

                                                                               /s/ Sherb & Co., LLP 

Certified Public Accountants

24

 
 
 
 
 
Celsius Holdings, Inc. and Subsidiaries
Consolidated Balance Sheets

ASSETS

LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)

Current assets:
Cash and cash equivalents
Accounts receivable, net
Inventories, net
Other current assets

Total current assets

Property, fixtures and equipment, net
Note receivable
Other long-term assets

Total Assets

Current liabilities:
Accounts payable and accrued expenses
Loans payable
Deposit from customer
Short term portion of other liabilities
Convertible note payable, net of debt discount
Due to related parties, short-term portion

Total current liabilities

Convertible note payable, net of debt discount
Due to related parties, long-term portion
Other liabilities

Total Liabilities

Stockholders’ Equity (Deficit):
Preferred stock, $0.001 par value; 50,000,000 shares authorized,
  4,000 shares and 0 shares issued and outstanding, respectively
Common stock, $0.001 par value: 350,000,000 shares
  authorized, 149 million and 106 million shares
  issued and outstanding, respectively
Additional paid-in capital
Accumulated deficit

Total Stockholders’ Equity (Deficit)

Total Liabilities and Stockholders’ Equity (Deficit)

See Notes to Consolidated Financial Statements
25

December 31,
2008

  December 31,

2007

  $

  $

  $

1,040,633    $
192,779     
505,009     
12,155     
1,750,576     

183,353     
250,000     
18,840     
2,202,769    $

612,044    $
95,000     
-     
26,493     
-     
120,000     
853,537     

562,570     
700,413     
75,022     
2,191,542     

257,482 
276,877 
578,774 
44,960 
1,158,093 

64,697 
1,250,000 
60,340 
2,533,130 

594,828 
710,307 
400,000 
7,184 
199,692 
896,721 
2,808,732 

1,314,914 
- 
14,236 
4,137,882 

4,000,000     

- 

148,789     
7,244,806     
(11,382,368)    
11,227     
2,202,769    $

105,611 
4,410,405 
(6,120,768)
(1,604,752)
2,533,130 

  $

 
 
 
 
 
 
 
 
 
   
 
 
   
     
 
   
     
 
   
   
   
   
 
   
      
  
   
   
   
 
   
      
  
 
   
      
  
   
   
   
   
   
   
 
   
      
  
   
   
   
   
 
   
      
  
   
      
  
   
      
  
   
   
      
  
   
      
  
   
   
   
   
 
 
Revenue

Cost of revenue

 Gross profit

Operating expenses:
Selling and marketing expenses
General and administrative expenses
Termination of contract expense

 Total operating expenses

Operating loss

Other expenses:
Interest income
Interest expense, related party
Interest expense, other, net

 Total other expenses

Net loss

Loss per share, basic and diluted

Weighted average shares outstanding -
basic and diluted

Celsius Holdings, Inc. and Subsidiaries
Consolidated Statements of Operations

See Notes to Consolidated Financial Statements
26

  For the years ended December 31,  

2008
2,589,887    $

2007
1,644,780 

  $

1,833,184     

1,033,971 

756,703     

610,809 

3,936,552     
1,740,143     
-     

2,100,687 
1,554,510 
500,000 

5,676,695     

4,155,197 

(4,919,992)    

(3,544,388)

70,441     
(773)    
(411,276)    

7,837 
(75,647)
(113,643)

(341,608)    

(181,453)

  $

(5,261,600)   $

(3,725,841)

  $

(0.04)    $

(0.04) 

128,703,645     

100,688,634 

 
 
 
 
 
 
 
 
 
   
 
 
   
      
  
   
 
   
      
  
   
 
   
      
  
   
      
  
   
   
   
 
   
      
  
   
 
   
      
  
   
 
   
      
  
   
      
  
   
   
   
 
   
      
  
   
 
   
      
  
 
   
      
  
 
   
      
  
 
   
      
  
   
      
  
   
 
Celsius Holdings, Inc. and Subsidiaries
Consolidated Statements of Changes in Stockholders’ Equity (Deficit)
for the Years Ended December 31, 2008 and 2007

Preferred Stock

Common Stock

Shares

Amount

Shares

Amount

Additional
Paid-In
Capital

    Accumulated    
Deficit

Total

Balance at December 31,
2006

Effect of recapitalization
due to merger
Issuance of common
stock in exchange of note    
Issuance of common
stock for cash
Exercise of warrants
Shares issued as
compensation for services    
Shares issued for
termination of contract
Beneficial conversion
feature of debt instrument    
Stock option expense
Net loss
Balance at December 31,
2007

Issuance of preferred
stock for cash
Issuance of stock in
exchange of note
Issuance of common
stock for cash
Exercise of stock options    
Shares issued as
compensation
Beneficial conversion
feature of debt instrument    
Stock option expense
Net loss
Balance at December 31,
2008

- 

 $

- 

69,575,000 

 $

69,575 

 $

705,425 

 $

(2,394,927)   $

(1,619,927)

24,000,000 

24,000 

329,117     

500,000 

5,013,800 
3,557,812 

1,572,246 

1,391,500 

500 

5,014 
3,558 

1,572 

1,392 

249,500     

1,777,720     
496,442     

196,928     

273,154     

243,838     
138,281     

353,117 

250,000 

1,782,734 
500,000 

198,500 

274,546 

243,838 
138,281 
(3,725,841)

(3,725,841)    

- 

105,610,358 

105,611 

4,410,405 

(6,120,768)    

(1,604,752)

3,500,000     

500,000 

29,030,661 

13,198,529 
16,671 

933,135 

29,030 

13,198 
17 

933 

1,550,533     

785,802     
295     

130,517     

170,460     
196,794     

(5,261,600)    

3,500,000 

2,079,563 

799,000 
312 

131,450 

170,460 
196,794 
(5,261,600)

- 

3,500 

500 

4,000 

 $

4,000,000 

148,789,354 

 $

148,789 

 $

7,244,806 

 $

(11,382,368)   $

11,227 

See Notes to Consolidated Financial Statements
27

 
 
 
 
 
   
     
   
     
     
 
 
 
   
   
 
 
 
   
   
   
   
   
     
 
 
   
     
     
     
     
     
     
 
  
  
 
   
      
      
      
      
      
      
  
   
      
  
  
  
  
      
      
  
  
  
  
      
   
      
  
  
  
  
      
   
      
  
  
  
  
      
      
  
  
  
  
      
   
      
  
  
  
  
      
      
      
      
  
  
      
   
      
      
      
  
  
      
   
      
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
   
      
      
      
      
      
      
  
  
  
      
      
      
      
  
  
  
  
  
      
   
      
  
  
  
  
      
      
  
  
  
  
      
   
      
  
  
  
  
      
      
      
      
  
  
      
   
      
      
      
  
  
      
   
      
  
  
  
  
  
  
  
  
  
  
 
  
  
  
  
  
  
  
  
  
  
  
      
  
 
 
Celsius Holdings, Inc. and Subsidiaries
Consolidated Statements of Cash Flows

Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash
used in operating activities:

Depreciation
Loss on disposal of assets
Adjustment to allowance for doubtful accounts
Adjustment to reserve for inventory obsolescence
Impairment of intangible assets
Termination of contract
Issuance of stock options
Amortization of debt discount
Issuance of shares as compensation
Changes in operating assets and liabilities:

Accounts receivable
Inventories
Prepaid expenses and other assets
Accounts payable and accrued expenses
Deposit from customer

Net cash used in operating activities

Cash flows from investing activities:
Purchases of intangible assets
Purchases of property, fixtures and equipment

Net cash used in investing activities

Cash flows from financing activities:

Proceeds from sale of common stock
Proceeds from sale of preferred stock
Proceeds from issuance of convertible notes
Proceeds from exercise of warrants
Proceeds from recapitalization due to merger
Repayment of note to stockholders
Proceeds from note receivable
Proceeds from loans payable
Repayment of loans payable
Repayment of note to related parties
Net cash provided by financing activities
Increase in cash

Cash, beginning of year
Cash, end of year

Supplemental disclosures of cash flow information:

 Cash paid during the year for interest
 Cash paid during the year for taxes

See Notes to Consolidated Financial Statements
28

  For the Years Ended December 31, 

2008

2007

  $

(5,261,600)   $

(3,725,841)

31,605     
804     
53,101     
190,601     
41,500     
-     
196,794     
211,245     
131,450     

11,658 
- 
- 
16,444 
26,000 
500,000 
138,281 
7,732 
198,500 

30,997     
(116,836)    
32,805     
17,382     
(400,000)    
(4,840,152)    

(148,558)
(30,119)
(8,906)
64,123 
400,000 
(2,550,686)

-     
(151,065)    
(151,065)    

(41,500)
(46,164)
(87,664)

799,312     
3,500,000     
990,900     
-     
-     
-     
1,000,000     
743,552     
(1,183,087)    
(76,309)    
5,774,368     
783,151     

257,482     
1,040,633    $

190,826    $
-    $

1,782,734 
- 
500,000 
500,000 
353,117 
( 621,715)
- 
483,891 
(24,325)
(106,449)
2,867,253 
228,903 

28,579 
257,482 

107,364 
- 

  $

  $
  $

 
 
 
 
 
 
   
 
   
     
 
   
      
  
   
      
  
   
   
   
   
   
   
   
   
   
   
      
  
   
   
   
   
   
   
 
   
      
  
   
      
  
   
   
   
 
   
      
  
   
      
  
   
   
   
   
   
   
   
   
   
   
   
   
 
   
      
  
   
   
      
  
 
CELSIUS HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

1.    ORGANIZATION AND DESCRIPTION OF BUSINESS

Business  —Celsius  Holdings,  Inc.  (f/k/a  Vector  Ventures  Corp.,  the  "Company”)  was  incorporated  under  the  laws  of  the  State  of  Nevada  on  April  26,
2005.  The Company was formed to engage in the acquisition, exploration and development of natural resource properties. On December 26, 2006 the Company
amended its Articles of Incorporation to change its name from Vector Ventures Corp. as well as increase the authorized shares to 350,000,000, $0.001 par value
common shares and 50,000,000, $0.001 par value preferred shares.

Prior to January 26, 2007, the Company was in the exploration stage with its activities limited to capital formation, organization, development of its business plan
and acquisition of mining claims.  On January 24, 2007, the Company entered into a merger agreement and plan of reorganization with Celsius, Inc., a Nevada
corporation and wholly-owned subsidiary of the Company ("Sub”), Elite FX, Inc., a Florida corporation ("Elite”), and Steve Haley, the "Indemnifying Officer” and
"Securityholder Agent” of Elite, (the "Merger Agreement”). Under the terms of the Merger Agreement Elite was merged into Sub and became a wholly-owned
subsidiary of the Company on January 26, 2007 (the "Merger”).

Under the terms of the Merger Agreement, the Company issued:

·  70,912,246 shares  of  its  common  stock  to  the  stockholders  of  Elite,  including 1,337,246  shares  of  common  stock  issued  as  compensation,  as  full

consideration for the shares of Elite;

·  warrants to Investa Capital Partners Inc. to purchase 3,557,812 shares of common stock of the Company for $500,000. The warrants were exercised

in February 2007;

·  1,391,500 shares of its common stock as partial consideration for termination of a consulting agreement and assignment of certain trademark rights to

the name "Celsius”;

·  options to purchase 10,647,025 shares of common stock of the Company in substitution for the options currently outstanding in Elite;

·  1,300,000 shares of its common stock concurrent with the Merger in a private placement to non-US resident investors for aggregate consideration of

US$650,000 which included the conversion of a $250,000 loan to the Company.

Celsius Holdings, Inc’s majority stockholder, Mr. Kristian Kostovski, cancelled 7,200,000 shares of common stock of the Company held by him shortly after the
close of the Merger Agreement.

For financial accounting purposes, the Merger was treated as a recapitalization of Celsius Holdings, Inc with the former stockholders of the Celsius Holdings, Inc
retaining approximately 24.6% of the outstanding stock. This transaction has been accounted for as a reverse acquisition and accordingly the transaction has been
treated as a recapitalization of Elite FX, Inc., with Elite FX, Inc. as the accounting acquirer. The historical financial statements are a continuation of the financial
statements of the accounting acquirer, and any difference of the capital structure of the merged entity as compared to the accounting acquirer’s historical capital
structure is due to the recapitalization of the acquired entity.

29

 
 
 
 
 
 
 
 
 
 
 
 
 
 
CELSIUS HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)

2.    BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Going  Concern  —  The  accompanying  consolidated  financial  statements  are  presented  on  a  going  concern  basis.  The  Company  has  suffered  losses  from
operations and has an accumulated deficit and net cash used in operations of $4,840,152 for the year ended December 31, 2008. This raises substantial doubt
about its ability to continue as a going concern. Management is currently seeking new capital or debt financing to provide funds needed to increase liquidity, fund
growth, and implement its business plan. However, no assurances can be given that the Company will be able to raise any additional funds. If not successful in
obtaining financing, the Company will have to substantially diminish or cease its operations. The financial statements do not include any adjustments that might
result from the outcome of this uncertainty.

Consolidation Policy — The accompanying consolidated financial statements include the accounts of Celsius Holdings, Inc. and subsidiaries. All material inter-
company balances and transactions have been eliminated in consolidation.

Significant Estimates — The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of
America requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses and disclosure of
contingent assets and liabilities at the date of the financial statements. Actual results could differ from those estimates.

Concentrations of Risk — Substantially all of the Company’s revenue derives from the sale of the Celsius beverage.

The Company uses single supplier relationships for its raw materials purchases and filling capacity, which potentially subjects the Company to a concentration of
business risk. If these suppliers had operational problems or ceased making product available to the Company, operations could be adversely affected.

Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents. The Company places its
cash and cash equivalents with high-quality financial institutions. At times, balances in the Company’s cash accounts may exceed the Federal Deposit Insurance
Corporation limit.

Cash  and  Cash  Equivalents  —  The  Company  considers  all  highly  liquid  instruments  with  maturities  of  three  months  or  less  when  purchased  to  be  cash
equivalents. At December 31, 2008, the Company did not have any investments with maturities greater than three months.

Accounts Receivable  — Accounts  receivable  are  reported  at  net  realizable  value.  The  Company  establishes  an  allowance  for  doubtful  accounts  based  upon
factors pertaining to the credit risk of specific customers, historical trends, and other information. Delinquent accounts are written-off when it is determined that
the amounts are uncollectible. At December 31, 2008 and December 31 2007, there was an allowance for doubtful accounts of $53,101 and $0, respectively.

Inventories — Inventories include only the purchase cost and are stated at the lower of cost or market. Cost is determined using the FIFO method. Inventories
consist of raw materials and finished products. The Company writes down inventory during the period in which such materials and products are no longer usable
or marketable. At December 31, 2008 and December 31, 2007, there was a reserve for obsolescence of $207,045 and $16,444, respectively.

30

 
 
 
 
 
 
 
 
 
 
 
 
 
CELSIUS HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)

Property, Fixtures, and Equipment —  Furniture, fixtures and equipment are stated at cost less accumulated depreciation and amortization.  Depreciation of
furniture, fixtures, and equipment is calculated using the straight-line method over the estimated useful life of the asset generally ranging from three to seven
years.

Impairment of Long-Lived Assets — Asset impairments are recorded when the carrying values of assets are not recoverable.

The Company reviews long-lived assets to be held and used for impairment whenever events or changes in circumstances indicate that the carrying amount of an
asset may not be recoverable or at least annually. If the sum of the undiscounted expected future cash flows is less than the carrying amount of the asset, the
Company recognizes an impairment loss. Impairment losses are measured as the amount by which the carrying amount of assets exceeds the fair value of the
asset. When fair values are not available, the Company estimates fair value using the expected future cash flows discounted at a rate commensurate with the
risks associated with the recovery of the asset.

Intangible  Assets  —  Intangible  assets  consist  of  the  web  domain  name  Celsius.com  and  other  trademarks  and  trade  names,  and  are  subject  to  annual
impairment  tests.  This  analysis  will  be  performed  in  accordance  with  Statement  of  Financial  Standards  (‘‘SFAS’’)  No.  142,  Goodwill  and  Other  Intangible
Assets. Based upon impairment analyses performed in accordance with SFAS No. 142 in fiscal years 2008 and 2007, impairment was recorded of $41,500 and
$26,000, respectively. The impairment recorded was for expenses for trademarks, domain names and international registration of trademarks.

Revenue Recognition  —  Revenue  is  recognized  when  the  products  are  delivered,  invoiced  at  a  fixed  price  and  the  collectability  is  reasonably  assured. Any
discounts, sales incentives or similar arrangements with the customer are estimated at time of sale and deducted from revenue.

Advertising Costs — Advertising costs are expensed as incurred. The Company uses mainly radio, local sampling events and printed advertising. The Company
incurred advertising expense of $1.6 million and $535,000, during the fiscal years 2008 and 2007, respectively.

Research and Development — Research and development costs are charged to operations as incurred and consists primarily of consulting fees, raw material
usage and test productions of beverages. The Company incurred expenses of $261,000 and $214,000, during the fiscal years 2008 and 2007, respectively.

Fair Value of Financial Instruments — The carrying value of cash and cash equivalents, accounts receivable, and accounts payable approximates fair value.
The carrying value of debt approximates the estimated fair value due to floating interest rates on the debt.

Income Taxes — Income taxes are accounted for using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the
expected  future  tax  consequences  of  events  that  have  been  recognized  in  the  Company’s  financial  statements  or  tax  returns.  In  estimating  future  tax
consequences, the Company generally considers all expected future events other than changes in the tax law or rates. A valuation allowance is recorded when it
is deemed more likely than not that a deferred tax asset will be not realized.

31

 
 
 
 
 
 
 
 
 
 
 
 
CELSIUS HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)

Earnings per Share — Basic earnings per share are calculated by dividing income available to stockholders by the weighted-average number of common shares
outstanding during each period. Diluted earnings per share are computed using the weighted average number of common and dilutive common share equivalents
outstanding during the period. Dilutive common share equivalents consist of shares issuable upon conversion of preferred shares, exercise of stock options and
warrants (calculated using the reverse treasury stock method). Common share equivalents outstanding were 86,130,991 and 8,534,864, as of December 31, 2008
and 2007, respectively.

Reclassifications — Certain prior year amounts have been reclassified to conform to the current year presentation. Such reclassifications had no effect on the
reported net loss.

Share-Based Payments — In December 2004, the FASB issued SFAS No. 123(R) "Share-Based Payment," ("SFAS 123(R)”), which replaces SFAS No. 123
and  supersedes  APB  Opinion  No.  25.  Under  SFAS  123(R),  companies  are  required  to  measure  the  compensation  costs  of  share-based  compensation
arrangements  based  on  the  grant-date  fair  value  and  recognize  the  costs  in  the  financial  statements  over  the  period  during  which  employees  are  required  to
provide services. Share-based compensation arrangements include stock options, restricted share plans, performance-based awards, share appreciation rights and
employee share purchase plans. In March 2005, the SEC issued Staff Accounting Bulletin No.107 "SAB 107'. SAB 107 expresses views of the staff regarding
the  interaction  between  SFAS  123(R)  and  certain  SEC  rules  and  regulations  and  provides  the  staffs  views  regarding  the  valuation  of  share-based  payment
arrangements  for  public  companies.  Effective  January  1,  2006,  the  Company  has  fully  adopted  the  provisions  of  SFAS  123(R)  and  related  interpretations  as
provided by SAB 107. As such, compensation cost is measured on the date of grant as the fair value of the share-based payments. Such compensation amounts,
if any, are amortized over the respective vesting periods of the option grant.

Recent Accounting Pronouncements

In  September  2006,  the  FASB  issued  Statement  of  Financial  Standards  No.  157,  "Fair  Value  Measurements"  ("SFAS  157”).  SFAS  157  defines
fair  value,  establishes  a  framework  for  measuring  fair  value  in  accordance  with  accounting  principles  generally  accepted  in  the  United  States,  and
expands  disclosures  about  fair  value  measurements.  This  statement  does  not  require  any  new  fair  value  measurements;  rather,  it  applies  under  other
accounting pronouncements that require or permit fair value measurements. The provisions of SFAS 157 are effective for fiscal years beginning after November
15, 2007. The adoption of SFAS 157 did not have a material impact on the Company's consolidated financial position or results of operations.

In February 2007, FASB issued SFAS No. 159, "The Fair Value Option for Financial Assets and Financial Liabilities” ("SFAS 159”).  SFAS 159 permits entities
to  choose  to  measure  many  financial  instruments  and  certain  other  items  at  fair  value  and  establishes  presentation  and  disclosure  requirements  designed  to
facilitate comparisons between entities that choose different measurement attributes for similar types of assets and liabilities.  SFAS 159 is effective for financial
statements issued for fiscal years beginning after November 15, 2007.  The adoption of SFAS 159 did not have on the Company’s consolidated financial position
and results of operations.

32

 
 
 
 
 
 
 
 
CELSIUS HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)

In December 2007, the FASB issued SFAS No. 141 (revised 2007), Business Combinations ("SFAS 141R”). SFAS 141R significantly changes the accounting
for business combinations in a number of areas including the treatment of contingent consideration, pre-acquisition contingencies, transaction costs, in-process
research and development, and restructuring costs. In addition, under SFAS 141R, changes in an acquired entity’s deferred tax assets and uncertain tax positions
after the measurement period will impact income tax expense. SFAS 141R is effective for fiscal years beginning after December 15, 2008. The Company does
not anticipate that the adoption of SFAS 141R will have a material impact on its results of operations or financial condition.

In December 2007, the FASB issued SFAS No. 160, Noncontrolling Interests in Consolidated Financial Statements, an amendment of ARB No 51 ("SFAS
160”).  SFAS  160  changes  the  accounting  and  reporting  for  minority  interests,  which  will  be  recharacterized  as  noncontrolling  interests  and  classified  as  a
component of equity. This new consolidation method significantly changes the accounting for transactions with minority interest holders. SFAS 160 is effective
for fiscal years beginning after December 31, 2008. These standards will change our accounting treatment for business combinations on a prospective basis.

In April 2008, the FASB issued FSP FAS 142-3, "Determination of the Useful Life of Intangible Assets.” This guidance is intended to improve the consistency
between the useful life of a recognized intangible asset under SFAS No. 142, "Goodwill and Other Intangible Assets”, and the period of expected cash flows used
to measure the fair value of the asset under SFAS No. 141R when the underlying arrangement includes renewal or extension of terms that would require
substantial costs or result in a material modification to the asset upon renewal or extension. Companies estimating the useful life of a recognized intangible asset
must now consider their historical experience in renewing or extending similar arrangements or, in the absence of historical experience, must consider
assumptions that market participants would use about renewal or extension as adjusted for SFAS No. 142’s entity-specific factors. This standard is effective for
fiscal years beginning after December 15, 2008, and is applicable to the Company’s fiscal year beginning January 1, 2008. The Company does not anticipate that
the adoption of this FSP will have a material impact on its results of operations or financial condition.

In March 2008 and May 2008, respectively, the FASB issued the following statements of financial accounting standards, none of which is anticipated to have a
material impact on the Company’s results of operations or financial position:

·  SFAS No. 161, "Disclosures about Derivative Instruments and Hedging Activities — an amendment of FASB Statement No. 133;”
·  SFAS No. 162, "The Hierarchy of Generally Accepted Accounting Principles;” and
·  SFAS No. 163, "Accounting for Financial Guarantee Insurance Contracts-an interpretation of FASB Statement No. 60.”

3.    INVENTORIES

Inventories consist of the following at:

Finished goods
Raw Materials
Less: inventory valuation allowance
Inventories, net

  December 31,     December 31,  

2008

2007

  $

  $

581,970    $
130,084     
(207,045)   
505,009    $

407,972 
187,246 
(16,444)
578,774 

33

 
 
 
 
 
 
 
 
 
 
 
   
 
   
   
 
   
      
  
 
 
 
CELSIUS HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)

4.    OTHER CURRENT ASSETS

Other current assets at December 31, 2008 and December 31, 2007 consist of deposits on purchases, prepaid insurance, other accounts receivable and accrued
interest receivable.

5.     PROPERTY, FIXTURES, AND EQUIPMENT

Property, fixtures and equipment consist of the following at:

Furniture, fixtures and equipment
Less: accumulated depreciation
Total

December 31,
2008

December 31,
2007

  $

  $

228,332    $
(44,979)   
183,353    $

78,425 
(13,728)
64,697 

Depreciation expense amounted to $31,605 and $11,658 during the fiscal years 2008 and 2007, respectively.

6.    OTHER LONG-TERM ASSETS

Other long-term assets consist of the following at:

Long term deposit on office lease
Intangible assets
Less: Impairment of intangible assets
Total

December 31,
2008

December 31,
2007

  $

  $

18,840    $
41,500     
(41,500)   
18,840    $

18,840 
41,500 
- 
60,340 

7.     NOTE RECEIVABLE

Note receivable from Golden Gate Investors, Inc. ("GGI”) was as of December 31, 2008 and December 31, 2007, $250,000 and $1,250,000, respectively. The
note is due on  February 1, 2012, under certain circumstances  GGI is obligated to monthly prepay $250,000 on the note.  During 2008,  GGI made four monthly
prepayments.  As  of  December  31,  2008  GGI  is  not  obligated  to  prepay  the  note.  The  prerequisites  to  obligate  GGI  to  prepay  the  note  are  outside  of  the
Company’s control and may exist at a future date.  The note accrues 8% interest per annum. The Company has an outstanding debenture to the same company
in the amount of $701,000. Also see Note 14  -  Long term debenture

8.    ACCOUNTS PAYABLE AND ACCRUED EXPENSES

Accounts payable and accrued expenses consist of the following at:

Accounts payable
Accrued expenses
Total

December 31,
2008

December 31,
2007

  $

  $

411,185    $
200,859     
612,044    $

466,047 
128,781 
594,828 

34

 
 
 
 
 
 
 
   
 
   
 
 
 
 
 
 
   
 
   
   
 
   
      
  
 
 
 
 
 
   
 
   
 
 
CELSIUS HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)

9.    DUE TO RELATED PARTIES

Due to related parties consists of the following as of:

The Company received advances from one of its shareholders at various instances during 2004 and 2005, $76,000
and  $424,000,  respectively.  In July,  2008,  the  debt  was  refinanced,  has  no  collateral  and  accrues interest  at  the
prime  rate.  Monthly  amortization  of  $5,000  is  due  and  a balloon  payment  of  approximately  $606,000  is  due  in
January 2010.

  $

643,916    $

669,111 

  December 31,     December 31,  

2008

2007

The Company’s CEO loaned the Company $50,000 in February 2006. Moreover, the Company accrued salary for
the  CEO  from  March  of  2006  through  May  2007  for a  total  of  $171,000.  In  August  2008,  the  total  debt  was
refinanced,  has  no collateral  and  accrues  interest  at  3%;  monthly  payments  of  $5,000  are  due with  a  balloon
payment of $64,000 in January 2011.

Less: Short-term portion
Long-term portion

Also, see Note 16 – Related party transactions.

10.  LOANS PAYABLE

Loans payable consist of the following as of:

  $
  $
 $

176,497     
820,413    $
(120,000)   $
700,413    $

227,610 
896,721 
(896,721)
- 

  December 31,

2008

    December 31,  
2007

a.

b.

The Company renewed its financing agreement for inventory on February 28, 2008. The line of credit was
for $500,000 and carried an interest charge of 1.5 percent of the outstanding balance and a monitoring fee
of 0.5 percent of the previous month’s average outstanding balance. The line of credit had as collateral all
of  the  Company’s  assets.  The  Company terminated  the  credit  agreement  and  paid  balance  owed  in
December 2008.

  $

The Company  renewed  its  factoring  agreement  for  the  Company’s  accounts receivable  during  the  first
quarter  of  2008.  The  maximum  finance  amount under  the  agreement  was  $500,000.  Each  factoring  of
accounts receivable has a fixed fee of one and a half percent of the invoice amount, a minimum fee per
month and an interest charge of prime rate plus three percent on the outstanding balance under the credit
agreement. The line of credit had as collateral all of the Company’s assets. The Company terminated the
factoring agreement and paid balance owed in November 2008.

-    $

222,092 

-     

102,540 

35

 
 
 
 
 
 
   
 
 
   
      
  
   
 
 
 
 
 
   
 
 
 
 
   
 
 
 
 
    
   
      
  
 
 
   
 
 
CELSIUS HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)

  December 31,     December 31,  

2008

2007

c.

d.

 In April 2, 2007 the Company received a $250,000 loan from Brennecke Partners LLC. In January, 2008 the
Company restructured the then outstanding balance of the note and issued 1 million shares for an equivalent
value of $121,555, and a new non-interest bearing note for $105,000. The Company paid the balance owed in
December, 2008.

The Company  terminated  a  consulting  agreement  and  received  in  assignment  the rights  to  the  trademark
"Celsius” from one of its former directors. Payment was issued in the form of an interest-free note payable
for $250,000  and  1,391,500  shares  of  common  stock.  The  note  called  for  monthly amortization  of  $15,000
beginning March 30, 2007 with final payment of the remaining outstanding balance on November 30, 2007.

  $

-     

225,675 

95,000     
95,000    $

160,000 
710,307 

11.  DEPOSIT FROM CUSTOMER

During 2007, the Company received $400,000 from an international customer as deposit on future orders. The deposit was used in its entirety to pay for product
shipped in April and June of 2008. The current balance as of December 31, 2008 and December 31, 2007 was $0 and $400,000, respectively.

12.  CONVERTIBLE AND OTHER NOTE PAYABLE

On December 18, 2007 the Company issued a $250,000 convertible note to CD Financial LLC ("CD”). The loan incurs eight percent interest per annum, and the
note was due on April 16, 2008. The note can be converted to Company common stock after February 16, 2008 at a rate equal to seventy five percent of the
average of the previous five days volume weighted average price for trading of the common stock, nevertheless, in no case can the note be converted to more
than 25 million shares of common stock. At the time of recording the note a beneficial conversion feature for the conversion option was recorded in the amount
$57,219, of which $6,199 was amortized in 2007, and $51,020 in 2008. Total outstanding as of December 31, 2007 was $199,692, which is net of debt discount of
$51,020. On April 4, 2008 the Company received an additional $500,000 from CD on the same terms as the first note, also extending the due date of the first
note. At the time of recording the second note a beneficial conversion feature for the conversion option was recorded as a debt discount in the amount $154,835.
On June 10, 2008, the total amount of $750,000 was converted to 11,184,016 shares of Common Stock. The Company amortized $106,948 of the debt discount as
interest expense; the remaining balance of the debt discount at time of conversion reduced the amount credited to equity.

On June 5, 2008, the Company issued a third convertible note for $250,000 to CD. On July 15, 2008 the Company issued a fourth convertible note for $250,000 to
CD.  The notes carry 8 percent interest. At the time of recording the first note a beneficial conversion feature for the conversion option was recorded in the
amount $15,625, of which $6,621 was amortized in June of 2008. On August 8, 2008, the convertible notes in the aggregate amount of $500,000 were cancelled
and exchanged as partial consideration for preferred stock issued to CDS Ventures of South Florida, LLC, an affiliate of CD.

36

 
 
 
 
   
 
 
 
 
   
 
 
 
   
 
    
   
      
  
 
 
   
 
    
 
 
 
 
 
 
 
CELSIUS HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)

In  December  2008,  the  Company  entered  into  a  $1  million  revolving  line  of  credit  with  CD  and  it  carries  interest  of  Libor  plus  three  percentage  points.  In
connection with this line of credit, the Company entered into a loan and security agreement under which it has pledged all of its assets as security for the line of
credit. At December 31, 2008, there was no outstanding balance for the line of credit.

In November and December 2008, the Company received loans from CD in the amount of $450,000 and $200,000, respectively. These loans incurred 10 percent
interest per annum and were paid off in December 2008.

13.  OTHER LIABILITY

During 2006 and 2008, the Company acquired a copier and 8 delivery vans, all of them financed. The outstanding balance on the aggregate loans as of December
31, 2008 and December 31, 2007 was $101,515 and $21,420, respectively, of which $26,493 and $7,184, is due during the next 12 months, respectively. The loans
carry interest ranging from 5.4% to 9.1%. The total monthly principal payment is $2,099. The assets that were purchased are collateral for the loans.

14.  LONG TERM DEBENTURE

On  December  19,  2007,  the  Company  entered  into  a  $6  million  security  purchase  agreement  (the  "Security  Agreement”)  with  Golden  Gate  Investors,  Inc
("GGI”),  a  California  corporation.  Under  the  Security  Agreement,  the  Company  issued  as  a  first  tranche  a  $1.5  million  convertible  debenture  maturing  on
December 19, 2011. The debenture accrues seven and 3/4 percent interest per annum.  As consideration the Company received $250,000 in cash and a note
receivable for $1,250,000. The note receivable accrues eight percent interest per annum and is due on February 1, 2012. The note has a pre-payment obligation of
$250,000 per month when certain criteria are fulfilled. The Company is not obligated to convert the debenture to shares, partially or in full, unless GGI prepays the
respective portion of its obligation under the note. The Security Agreement contains three more identical tranches for a total agreement of $6 million. Each new
tranche  can  be  started  at  any  time  by  GGI  during  the  debenture  period  which  is  defined  as  between  December  19,  2007  until  the  balance  of  the  existing
debentures is $250,000 or less. Either party can, with a penalty payment of $45,000 for the Company, and $100,000 for GGI, cancel any or all of the three pending
tranches.

The debenture is convertible to common shares at a conversion rate of eighty percent of the average of the three lowest volume weighted average prices for the
previous 20 trading days. The Company is not obligated to convert the amount requested to be converted into Company common stock, if the conversion price is
less than $0.20 per share. GGI’s ownership in the company cannot exceed 4.99% of the outstanding common stock. Under certain circumstances the Company
may be forced to pre-pay the debenture with a fifty percent penalty of the pre-paid amount.

37

 
 
 
 
 
 
 
 
 
 
CELSIUS HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)

The Company recorded a debt discount of $186,619 with a credit to additional paid in capital for the intrinsic value of the beneficial conversion feature of the
conversion option at the time of issuance. The debt discount is being amortized over the term of the debenture. The Company recorded $46,656 and $1,533 as
interest expense amortizing the debt discount during 2008 and 2007, respectively. The Company considered SFAS 133 and EITF 00-19 and concluded that the
conversion  option  should  not  be  bifurcated  from  the  host  contract  according  to  SFAS  133  paragraph  11  a,  and  concluded  that  according  to  EITF  00-19  the
conversion option is recorded as equity and not a liability.

During  2008,  the  Company  received  $1,000,000  in  payment  on  the  note  receivable.  In  June  to  December,  2008,  the  Company  converted  $774,000  of  the
debenture to approximately 16.9 million shares of Common Stock and the Company paid $25,000 of the debenture in cash.

The outstanding liability, net of debt discount, as of December 31, 2008 and December 31, 2007 was $562,570 and $1,314,914, respectively.

15.  PREFERRED STOCK

On August 8, 2008, the Company entered into a securities purchase agreement ("SPA1”) with CDS Ventures of South Florida, LLC ("CDS”), an affiliate of CD
Financial, LLC ("CD”). Pursuant to the SPA, the Company issued 2,000 Series A preferred shares ("Preferred A Shares”), as well as a warrant to purchase an
additional 1,000 Preferred A Shares, for a cash payment of $1.5 million and the cancellation of two notes in aggregate amount of $500,000 issued to CD. The
Preferred A Shares can be converted into Company common stock at any time; until December 31, 2010, (as amended on December 12, 2008), the conversion
price  is  $0.08,  after  which  the  conversion  price  is  the  greater  of  $0.08  or  90%  of  the  volume  weighted  average  price  of  the  Common  Stock  for  the  prior  10
trading days. Pursuant to the SPA1, the Company entered into a registration rights agreement under which the company agreed to file a registration statement for
the common stock issuable upon conversion of Preferred Shares. The Preferred A Shares accrue a ten percent annual cumulative dividend, payable in additional
Preferred A Shares. The Preferred A Shares mature on February 1, 2013 and is redeemable only in Company Common Stock.

On December 12, 2008, the Company entered into a securities purchase agreement ("SPA2”) with CDS. Pursuant to the SPA2 the Company issued 2,000 Series
B  preferred  shares  ("Preferred  B  Shares”),  as  well  as  a  warrant  to  purchase  additional  2,000  Preferred  B  Shares,  for  a  cash  payment  of  $2.0  million.  The
Preferred  B  Shares  can  be  converted  into  Company  common  stock  at  any  time,  until  December  31,  2010,  the  conversion  price  is  $0.05,  after  which  the
conversion price is the greater of $0.05 or 90% of the volume weighted average price of the common stock for the prior 10 trading days. Pursuant to the SPA2,
the Company entered into a registration rights agreement under which the company agreed to file a registration statement for the common stock issuable upon
conversion  of  Preferred  B  Shares.  The  Preferred  B  Shares  accrue  a  ten  percent  annual  cumulative  dividend,  payable  in  additional  Preferred  B  Shares.  The
Preferred B Shares mature on December 31, 2013 and is redeemable only in Company Common Stock.

38

 
 
 
 
 
 
 
 
 
 
CELSIUS HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)

Certain covenants of both Series A and B preferred shares restrict the Company to enter into additional debt or to permit liens to be filed against the Company’s
assets, without approval from the holder of the preferred shares. There is a mandatory redemption in cash, if the Company breaches certain covenants of the
agreements. The holders have liquidation preference in case of company liquidation. The Company has the right to redeem the preferred shares early in cash at
104% of the liquidation preference value for Series A, any date after July 1, 2010 and for Series B, any date after January 1, 2011.

16.  RELATED PARTY TRANSACTIONS

The  CEO  has  guaranteed  the  Company’s  obligations  under  the  factoring  agreement  with  Bibby  Financial  Services,  Inc.  ("Bibby”),  the  outstanding  balance  to
Bibby as of  December 31, 2008 and  December 31, 2007 was $0 and $102,540, respectively.  The  CEO has also guaranteed the financing for the  Company’s
offices and purchases of vehicles. The CEO has not received any compensation for the guarantees.

The COO of the Company lent the Company $50,000 in February 2008, the loan was repaid in March 2008. The COO also purchased in February 2008, 781,250
shares in a private placement for a total consideration of $75,000.

The  CFO  of  the  Company  lent  the  Company  $25,000  in  February  2008,  the  loan  was  repaid  in  February  2008.  The  CFO  also  purchased  in  February  2008,
245,098 shares in a private placement for a total consideration of $25,000.

The Vice President of Strategic Accounts and Business Development purchased in February 2008, 245,098 shares in a private placement for a total consideration
of $25,000.

Also, see Note 9 – Due to related parties.

17.  STOCKHOLDERS’ DEFICIT

Issuance of common stock pursuant to conversion of note

During 2007, the Company issued 500,000 shares as conversion of a note for $250,000, or an average price of $0.50 per share.

In January 2008, the Company restructured the then outstanding balance of a note and issued 1 million unregistered shares for an equivalent value of $121,555,
and  a  new  non-interest  bearing  note  for  $105,000.  The  note  calls  for  7  monthly  principal  payments  beginning  March  1,  2008.  The  Company  paid  off  the
outstanding balance as of December 31, 2008.

In June 2008, the Company issued 11,184,016 unregistered shares as conversion of notes for $750,000 that were originally issued in December 2007 and April
2008.

In  June  through  September,  2008,  the  Company  issued  9,107,042  as  a  partial  conversion  of  a  debenture  for  $575,000  originally  issued  in  December  2007.  In
October through December, 2008, the Company issued 7,739,603 shares as a partial conversion of the same debenture for $199,000.

39

 
 
 
 
 
 
 
 
 
 
 
 
 
 
CELSIUS HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)

Issuance of common stock pursuant to services performed and termination of contract

During  2007  the  Company  issued  1,572,246  shares  as  compensation  to  employees,  consultants  and  service  providers.  The  total  consideration  recorded  was
$198,500 or an average of $0.13 per share.

In January, 2007, the Company issued 1,391,500 shares to a director as part of the consideration for termination of a consulting contract. The total consideration
recorded was $274,546, or an average of $0.20 per share.

In March 2008, the Company issued a total of 750,000 unregistered shares as compensation to an international distributor at a fair value of $120,000.

In  September through  December, 2008, the  Company issued a total of 183,135 unregistered shares as compensation to a consultant and a distributor at a fair
value of $11,450.

Issuance of common stock pursuant to exercise of warrant and stock options

In February 2007, an investor exercised its warrant to purchase 3,557,812 shares for a total consideration of $500,000, or an average of $0.14 per share.

On February 15, 2008 the Company issued 16,671 shares of unregistered common stock in accordance to its 2006 Stock Incentive Plan to an employee exercising
vested options.

Issuance of common stock pursuant to private placements

On June 22, 2007, the Company entered into a $16 million common stock purchase agreement (the "Purchase Agreement”) with Fusion Capital Fund II, LLC
("Fusion”),  an  Illinois  limited  liability  company.  Under  the  Purchase  Agreement,  the  Company  received  $500,000  from  Fusion  Capital  on  the  signing  of  the
agreement and received additional $500,000 on July 20, 2007 when a registration statement related to the transaction was filed with the SEC. Concurrently with
entering  into  the  Purchase  Agreement,  the  Company  entered  into  a  registration  rights  agreement  (the  "Registration  Agreement”)  with  Fusion.  Under  the
Registration Agreement, we filed a registration statement with the SEC covering the shares that have been issued or may be issued to Fusion under the common
stock purchase agreement. The SEC declared effective the registration statement on October 12, 2007 and the Company has the right over a 25-month period to
sell our shares of common stock to  Fusion from time to time in amounts between $100,000 and $1 million, depending on certain conditions as set forth in the
agreement, up to an additional $15 million.

In consideration for entering into the $16 million Purchase Agreement, which provides for up to $15 million of future funding as well as the $1 million of funding
prior to the registration statement being declared effective by the SEC, we agreed to issue to Fusion 3,168,305 shares of our common stock. The purchase price
of the shares related to the $15 million of future funding will be based on the prevailing market prices of the Company’s shares at the time of sales without any
fixed discount, and the Company will control the timing and amount of any sales of shares to Fusion. Fusion shall not have the right or the obligation to purchase
any shares of our common stock on any business day that the price of our common stock is below $0.45. The Purchase Agreement may be terminated by us at
any time at our discretion without any cost to us. The Company has sold to Fusion 795,495 shares for a total consideration of $400,000, before expenses related to
the share issuances.

During 2007, the Company issued 5,013,800 shares to investors for a total consideration of approximately $1,783,000.

40

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CELSIUS HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)

In February 2008 the Company issued a total of 3,198,529 unregistered shares of common stock in private placements for an aggregate consideration of $298,900,
net of commissions.

In March 2008 the Company issued a total of ten million unregistered shares of common stock in a private placement, for an aggregate consideration of $500,100.
In addition, the investor received a warrant to purchase seven million unregistered shares of common stock during a 3-year period, at an exercise price of $0.13
per share. Of the total consideration, $100,000 was paid in March and $400,100 was paid on April 7, 2008.

Issuance of preferred stock pursuant to private placement

In August 2008, the Company issued 2,000 unregistered Preferred A Shares, as well as a warrant to purchase additional 1,000 Preferred A Shares, for a cash
payment of $1.5 million and the cancellation of two notes in aggregate amount of $500,000.

In December 2008, the Company issued 2,000 unregistered Preferred B Shares, as well as a warrant to purchase additional 2,000 Preferred B Shares, for a cash
payment of $2.0 million.

Also, see Note - 15 Preferred stock.

18.  INCOME TAXES

For the years ended December 31, 2008 and 2007, the Company’s net tax provision was zero.

The difference between the effective income tax rate and the United States federal income tax rate is summarized as follows:

Statutory federal rate
State income tax
Effect of permanent differences
Change in valuation allowance

The deferred tax asset consisted of the following at December 31:

Net operating losses
Other deferred tax assets
Valuation allowance
Total

2008

2007

(34.0%)   
(3.6%)   
3.0%    
34.6%    
0.0%    

(34.0%)
(3.6%)
1.6%
36.0%
0.0%

2008
3,803,000    $
206,000     
(4,009,000)   
0    $

2007
2,156,000 
79,000 
( 2,235,000)
0 

  $

  $

In assessing the ability to realize a portion of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred
tax assets will not be realized.  The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in
which  those  temporary  differences  become  deductible.  Management  considers  the  scheduled  reversal  of  deferred  tax  liabilities  and  projected  future  taxable
income in making the assessment. The valuation allowance for deferred tax assets as of December 31, 2008 and December 31, 2007 was $4.0 million and $2.2
million, respectively. The increase in valuation allowance was $1.8 million and $1.3 million in 2008 and 2007, respectively. The increase in valuation allowance
was primarily attributable to the increase in net operating losses. The Company has recorded a valuation allowance at December 31, 2008 of $4.0 million or 100%
of the assets.

41

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
   
   
   
 
   
 
 
 
   
 
   
   
 
   
      
  
 
 
 
CELSIUS HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)

Net operating loss carry forwards expire:

2024
2025
2026
2027
2028
Total

 $

 $

95,699 
787,446 
1,392,190 
3,303,187 
4,528,859 
10,107,381 

The Company’s net operating loss carry forwards may be limited due to ownership changes pursuant to Internal Revenue Code section 382.

In July 2006, the FASB issued Interpretation No. 48, "Accounting for Uncertainty in Income Taxes – an Interpretation of FASB Statement No. 109” (("FIN48”).
This Interpretation prescribes a consistent recognition threshold and measurement standard, as well as clear criteria for subsequently recognizing, derecognizing
and measuring tax positions for financial statement purposes. The Interpretation also requires expanded disclosure with respect to uncertainties as they relate to
income tax accounting. Fin 48 is effective for fiscal years beginning after December 15, 2006. Management has evaluated all of its tax positions and determined
that FIN 48 did not have a material impact on the Company’s financial position or results of operations during its year ended December 31, 2008.

19.  STOCK-BASED COMPENSATION

The Company adopted an Incentive Stock Plan on January 18, 2007. This plan is intended to provide incentives which will attract and retain highly competent
persons at all levels as employees of the Company, as well as independent contractors providing consulting or advisory services to the Company, by providing
them opportunities to acquire the  Company's common stock or to receive monetary payments based on the value of such shares pursuant to Awards issued.
While the plan terminates 10 years after the adoption date, issued options have their own schedule of termination. Until 2017, options to acquire up to 16.0 million
shares of common stock may be granted at no less than fair market value on the date of grant. Upon exercise, shares of new common stock are issued by the
Company.

The Company has issued approximately 13.4 million options to purchase shares at an average price of $0.07 with a fair value of $527,000. For the year ended
December  31,  2008  and  December  31,  2007,  the  Company  recognized  $196,794  and  $138,000,  respectively,  of  non-cash  compensation  expense  (included  in
General  and  Administrative  expense  in  the  accompanying  Consolidated  Statement  of  Operations).  As  of  December  31,  2008  and  December  31,  2007,  the
Company  had  approximately  $192,000  and  $488,000,  respectively,  of  unrecognized  pre-tax  non-cash  compensation  expense  which  the  Company  expects  to
recognize,  based  on  a  weighted-average  period  of  0.9  years.  The  Company  used  the  Black-Scholes  option-pricing  model  and  straight-line  amortization  of
compensation expense over the two to three year requisite service or vesting period of the grant. There are options to purchase approximately 5.1 million shares
that have vested, and 16,671 shares were exercised as of December 31, 2008. The following is a summary of the assumptions used:

42

 
 
 
  
  
  
  
 
  
  
 
 
 
 
 
 
CELSIUS HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)

Risk-free interest rate
Expected dividend yield
Expected term
Expected annual volatility

1.7% - 4.9%
—  
3 – 5  years
73% - 82%

Elite FX granted on January 19, 2007, prior to the merger with Celsius Holdings, Inc, equivalent to 1,337,246 shares of common stock in the Company, to its Chief
Financial Officer as starting bonus for accepting employment with the Company. The Company valued the grant of stock based on fair value of the shares, which
was estimated as the value of shares in the most recent transaction of the Company’s shares. The Company recognized the expense upon issuance of the grant.

 In March, 2008, the Company issued a total of 750,000 shares as compensation to an international distributor at a fair value of $120,000. The same agreement
can give the distributor 750,000 additional shares if certain sales targets are met, or if the stock price of the Company is 45 cents or greater for a period of 5
trading days, whichever occurs first.

During 2008 the Company issued a total of 183,135 shares as compensation to a consultant and a distributor at a fair value of $11,450. The consultant will receive
additional shares with fair value of $2,000 monthly as long as the consultancy agreement continues. The distributor can receive additional shares depending on its
purchases until end of March 2009.

The  following  table  summarizes  information  about  options  for  purchase  of  shares;  granted,  exercised  and  forfeited  during  the  two-year  period  ending
December 31, 2008:

Options
at December 31, 2006
Granted
Exercised
Forfeiture
At December 31, 2007
Granted
Exercised
Forfeiture
At December 31, 2008
Exercisable at December 31, 2008
Available for future grant

Weighted Average
Fair
Value

Exercise
Price

—    $

0.09 
— 
0.02 
0.02 
0.11 
0.02 
0.45 
0.07 
0.07 

 $

 $
 $

—     
0.05     
—     
0.01     
0.05     
0.07     
0.01     
0.26     
0.04     
0.04     

Weighted
Average
Remaining
Contractual  
Term
(in years)

6.7 

5.9 
5.1 

Shares
(in

 $

thousands)    
— 
11,872 
— 
(201)   
 $

11,671 
2,970 

(17)   
(1,177)   
 $
13,447 
5,088 
 $
2,475     

43

 
 
 
 
 
 
 
 
 
 
 
 
   
   
 
 
   
   
   
 
 
   
   
 
  
 
  
  
  
 
  
  
  
 
  
  
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
      
      
  
 
 
CELSIUS HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)

The following table summarizes information about options outstanding at December 31, 2008:

Range of Exercise
Price
$0.02
$0.08 - $0.11
$0.23 - $0.60
$0.84 - $1.10

Number
Outstanding at
December 31,
2008 (000s)

10,162
2,835
50
400
13,447

Weighted
Average
Remaining Life
5.4
5.9
8.8
8.5
5.6

  $
  $
  $
  $
  $

Weighted
Average
Exercise
Price

Number
Exercisable at
December 31,
2008 (000s)

Weighted
Average
Exercise
Price

0.02  
0.11  
0.42  
0.91  
0.07 

3,488  $
1,450  $
17  $
133  $
5,088  $

0.02  
0.11  
0.42  
0.91  
0.07  

Weighted
Average
Remaining
Life in
Years

5.4
4.3
8.8
8.5
5.1

The following table summarizes information about non-vested options outstanding at December 31, 2008:

Total Non-vested options
At December 31, 2006
Granted
Vested
Forfeited
At December 31, 2007
Granted
Vested
Forfeited
At December 31, 2008

20.  STOCK OPTIONS AND WARRANTS

Number of
shares
(000s)

Weighted
average Grant  
Date Fair
Value

-    
11,872   $
(134)   
(201)   
11,537   $
2,970   $
(5,171)   
(977)   
8,359   $

- 
0.05 
0.01 
 0.01 
0.06 
0.07 
0.05 
 0.27 
0.04 

Under  the  terms  of  the  Merger Agreement  with  Vector  Ventures,  Corp.,  see  further  Note  1  to  the  Consolidated  Financial  Statements,  the  Company  issued
warrants to Investa Capital Partners Inc. representing 3,557,812 shares of Common Stock of the Company, which were exercised on February 9, 2007 for an
aggregate consideration of $500,000 in cash.

An investment banking firm received, as placement agent for the Fusion Capital financing, a warrant to purchase 75,000 shares at a price of $1.31 per share. If
unexercised, the warrant expires on June 22, 2012.

In  March,  2008  the  Company  issued  a  total  of  10,000,000  unregistered  shares  of  common  stock  in  a  private  placement,  for  an  aggregate  consideration  of
$500,100. In addition, the investor received a warrant to purchase seven million unregistered shares of common stock at an exercise price of $0.13 per share. If
unexercised, the warrant expires on March 28, 2011.

44

 
 
 
 
 
  
  
  
 
 
 
 
 
 
 
 
 
  
 
 
 
   
 
 
   
 
  
  
  
  
  
  
  
  
  
 
 
 
 
 
 
CELSIUS HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)

On  August  8,  2008,  the  Company  entered  into  a  securities  purchase  agreement  with  CDS,  as  further  described  in  Note  15  to  the  Consolidated  Financial
Statements.  In  connection  with  the  security  purchase,  CDS  received  a  warrant  to  purchase  an  additional  1,000  Preferred A  Shares,  at  a  price  of  $1,000  per
share. If unexercised, the warrant expires on July 10, 2010. The Preferred A Shares can be converted into our common stock at any time; until the December 31,
2010, (as amended on December 12, 2008), the conversion price is $0.08, after which the conversion price is the greater of $0.08 or 90% of the volume weighted
average price of the common stock for the prior 10 trading days. The Preferred A Shares accrue ten percent annual cumulative dividend, payable in additional
Preferred A Shares.

On  December  12,  2008,  the  Company  entered  into  another  securities  purchase  agreement  with  CDS,  as  further  described  in  Note  15  to  the  Consolidated
Financial Statements. In connection with the security purchase, CDS received a warrant to purchase an additional 2,000 Preferred B Shares, at a price of $1,000
per share.  If unexercised, the warrant expires on  December 31, 2009.   The  Preferred  B  Shares can be converted into our common stock at any time.   Until
December 31, 2010, the conversion price is $0.05, after which the conversion price is the greater of $0.05 or 90% of the volume weighted average price of the
common stock for the prior 10 trading days. The Preferred B Shares accrue a ten percent annual cumulative dividend, payable in additional Preferred B Shares. 

Year Ended December 31,
2008

Year Ended December 31,
2007

  Thousands of   

  Warrants

Weighted
Average
Exercise
Price

    Thousands of   

    Warrants

Weighted
Average
Exercise
Price

Balance at the beginning of year
Granted
Exercised
Expired
Balance at the end of year

75    $
59,500    $
—     
—     
59,575    $

1.31     
0.07     
—     
—     
0.07     

—    $
3,633    $
3,558    $
—     
75    $

Warrants exercisable at end of year

59,575    $

0.07     

75    $

— 
0.16 
0.14 
— 
1.31 

1.31 

Weighted average fair value of the
warrants granted during the year

     $

0.03     

     $

1.85 

The  weighted  average  remaining  contractual  life  and  weighted  average  exercise  price  of  warrants  outstanding  and  exercisable  at  December  31,  2008,  for
selected exercise price ranges, is as follows:

Range of Exercise
Price
$0.05
$0.08
$0.13
$1.31

Weighted
Average
Remaining Life
1.0
1.5
2.2
3.6
1.3

Weighted
Average
Exercise
Price
$0.05
$0.08
$0.13
$1.31
$0.07

Number
Outstanding at
December 31,
2008 (000s)
40,000
12,500
7,000
75
59,575

45

 
 
 
 
 
 
   
 
 
 
 
   
   
 
   
   
   
   
   
 
   
      
      
      
  
   
 
   
      
      
      
  
   
 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
  
  
 
 
 
CELSIUS HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)

21.  OPERATING LEASES

The Company entered into a new office lease effective October 2008. The monthly rent amounts to $6,717 per month and the lease terminates in September
2009. Future annual minimum payments required under operating lease obligations at December 31, 2008 are as follows:

2009
2010 and thereafter
Total

22.  COMMITMENTS AND CONTINGENCIES

Future Minimum
Lease Payments

$

$

60,453 
0 
60,453 

The Company has entered into distribution agreements with liquidated damages in case the Company cancels the distribution agreements without cause. Cause
has been defined in various ways. It is the management belief that no such agreement has created any liability as of today’s date.

There is one agreement that also has liquidated damages, but instead of a monetary damage, the potential liability is to have to issue shares to the distributor at a
purchase price of $0.06. The quantity of shares depends on this distributor’s purchases from the Company as compared to the Company’s total revenue.

23.  BUSINESS AND CREDIT CONCENTRATION

Substantially all of the Company’s revenue derives from the sale of the Celsius beverage.

The Company uses single supplier relationships for its raw materials purchases and filling capacity, which potentially subjects the Company to a concentration of
business risk. If these suppliers had operational problems or ceased making product available to the Company, operations could be adversely affected. No vendor
accounted for more than 10% of total payments.

During 2008, the Company sold in one order to one international customer 15.9% of the Company’s total revenue for the year. There is no assurance that this
customer will order again.

24.  NON-CASH INVESTING AND FINANCING ACTIVITIES

For the years ended December 31,
Issuance of shares for note payable
Debt discount for beneficial conversion feature
Issuance of debenture for note receivable
Issuance of shares for termination of contract
Issuance of notes payable for termination of contract

2008
2,079,563   $
170,460   $
-   $
-   $
-   $

 $
 $
 $
 $
 $

2007
250,000 
243,838 
1,250,000 
274,546 
250,000 

46

 
 
 
 
 
 
 
 
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
ITEM 8             CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

On August 4, 2006, we received the resignation of our principal independent accountant, Armando C. Ibarra, C.P.A.

Armando C. Ibarra, C.P.A. had served as our principal independent accountant from inception (April 26, 2005) and the fiscal year September 2005, inclusive through
August 4, 2006.

The principal independent accountant’s report issued by Armando C. Ibarra, C.P.A. for the year ended September 30, 2005 did not contain any adverse opinion or
disclaimer of opinion and it was not modified as to uncertainty, audit scope, or accounting principles, other than their opinion, based on our lack of operations and our
net  losses,  there  was  substantial  doubt  about  our  ability  to  continue  as  a  going  concern.  The  financial  statements  did  not  include  any  adjustments  that  might  have
resulted from the outcome of that uncertainty.

We are able to report that during the year ended  September 30, 2005 through August 4, 2006 there were no disagreements with Armando  C.  Ibarra,  C.P.A., our
former principal independent accountant, on any matter of accounting principles or practices, financial statement  disclosure, or auditing scope or procedure, which, if
not resolved to Armando C. Ibarra, C.P.A.’s satisfaction, would have caused it to make reference to the subject matter of the disagreement(s) in connection with its
reports on our consolidated financial statements for such periods. We have requested that Armando C. Ibarra, C.P.A. furnish us with a letter addressed to the SEC
stating whether or not it disagrees with the above statements. A copy of such letter is filed herewith as Exhibit 16.1.

On August 4, 2006, upon authorization and approval of the Company’s Board of Directors, the Company engaged the services of Chang G. Park, CPA, Ph.D. as its
independent registered public accounting firm.

On March 8, 2007, the Company terminated Chang G. Park, CPA, Ph.D. ("Park”) as the Company’s independent registered public accounting firm. The decision to
dismiss Park was unanimously determined and approved by the Company’s Board of Directors.

The audit reports of Park on the financial statements of the Company as of and for the years ended September 30, 2005 and 2006 did not contain any adverse opinion
or disclaimer of opinion, nor were such reports qualified or modified as to uncertainty, audit scope or accounting principle. During the fiscal years ended September
30,  2005  and  2006  and  the  subsequent  interim  period  through  March  8,  2007,  there  were  no  disagreements  with  Park  on  any  matter  of  accounting  principles  or
practices,  financial  statement  disclosure,  or  auditing  scope  or  procedure,  which  disagreements,  if  not  resolved  to  the  satisfaction  of  Park,  would  have  caused  it  to
make reference thereto in its reports on the financial statements for such years.

In connection with the audits of the two (2) fiscal years ended September 30, 2005 and 2006 and the subsequent interim period through March 8, 2007, there have
been no "reportable events” (as defined in Item 304(a)(1)(v) of Regulation S-K).

On March 8, 2007, upon authorization and approval of the Company’s Board of Directors, the Company engaged Sherb & Co., LLP ("Sherb”) as the Company’s
independent registered public accounting firm.

47

 
 
 
 
 
 
 
 
 
 
 
 
During the Company’s fiscal years ended September 30, 2005 and 2006 and the subsequent interim period through March 8, 2007, neither the Company nor anyone
acting on its behalf consulted with Sherb regarding either (i) the application of accounting principles to a specific transaction, either completed or proposed, or the type
of audit opinion that might be rendered on the Company’s financial statements or (ii) any matter that was either the subject of a disagreement (as such term is defined
in Item 304(a)(1)(iv) of Regulation S-K), or a reportable event (as such term is described in Item 304(a)(1)(v) of Regulation S-K).

ITEM 8A          DISCLOSURE CONTROLS AND PROCEDURES 

Disclosure Controls and Procedures

Under  the  supervision  and  with  the  participation  of  our  management,  including  our  principal  executive  officer  and  principal  financial  officer,  we  conducted  an
evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) under the Securities Exchange
Act of 1934, as amended, as of the end of the period covered by this report (the "Evaluation Date”).  Based on this evaluation, our principal executive officer and
principal financial officer concluded as of the Evaluation Date that our disclosure controls and procedures were effective such that the information relating to Celsius
Holdings, Inc., including our consolidated subsidiaries, required to be disclosed in our Securities and Exchange Commission ("SEC”) reports (i) is recorded, processed,
summarized  and  reported  within  the  time  periods  specified  in  SEC  rules  and  forms  and  (ii)  is  accumulated  and  communicated  to  the  Company’s  management,
including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

Our  management,  including  our  Chief  Executive  Officer  and  Chief  Financial  Officer,  does  not  expect  that  our  disclosure  controls  and  procedures  or  our  internal
controls will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that
the objectives of the control system are met.   Further, the design of a control system must reflect the fact that there are resource constraints and the benefits of
controls must be considered relative to their costs. Due to the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that
all control issues and instances of fraud, if any, within the Company have been detected.

Management’s Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) under the Securities
Exchange Act, as amended).  Our management assessed the effectiveness of our internal control over financial reporting as of December 31, 2008.  In making this
assessment, our management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission ("COSO”) in Internal Control-
Integrated Framework.   Our management has concluded that, as of  December 31, 2008, our internal control over financial reporting is effective based on these
criteria.

Changes in Internal Control over Financial Reporting

Our  management  has  also  evaluated  our  internal  controls  over  financial  reporting,  and  there  have  been  no  significant  changes  in  our  internal  controls  or  in  other
factors that could significantly affect those controls subsequent to the date of their last evaluation.

48

 
 
 
 
 
 
 
 
 
ITEM 8B          OTHER INFORMATION 

Item 1.

There are no material legal proceedings pending against us.

Item 2. 

On January 22, 2008 the Company issued 1,000,000 unregistered common stock and a note for $105,000 to Brennecke Partners, LLC in exchange for the note issued
on April 7, 2007 and accrued interest having an aggregate value of $225,155.

On February 15, 2008 the Company issued 16,671 unregistered shares of common stock in accordance to its 2006 Stock Incentive Plan to an employee exercising
vested options.

In February, 2008 the Company issued a total of 3,198,529 unregistered shares of common stock in private placements for an aggregate consideration of $298,900, net
of commissions.

In  March,  2008  the  Company  issued  a  total  of  750,000  unregistered  shares  of  common  stock  as  compensation  to  an  international  distributor  for  an  aggregate
consideration of $120,000.

In March, 2008 the Company issued a total of 10,000,000 unregistered shares of common stock in a private placement, for an aggregate consideration of $500,100. In
addition, the investor received a warrant to purchase seven million unregistered shares of common stock during a 3-year period, at an exercise price of $0.13 per
share.

In  June 2008 the  Company issued 11.2 million unregistered shares as conversion for $750,000 convertible notes that were originally issued in  December 2007 and
April 2008.

In August 2008 the Company issued 2,000 unregistered preferred Series A shares for a consideration of $2.0 million, of which $500,000 was paid through cancellation
of two previously issued notes of $250,000 each and a cash payment of $1.5 million.

In June through December 2008, the Company issued 16.8 million shares of common stock as partial conversion of a convertible debenture issued in December 2007.

In September through December 2008 the Company issued 158,135 unregistered shares to a consultant with a fair value of $10,000 for services.

In September 2008 the Company issued 25,000 unregistered shares with a fair value of $1,450 to a distributor.

In December 2008, the Company issued 2,000 unregistered preferred Series B shares for a consideration of $2 million.

No commission or discounts were given in the transactions above, except for one of the private placements and no underwriter was engaged.

Defaults upon Senior Securities.

Not applicable.

Not applicable.

49

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
D I R E C TO R S, EXECUTIVE  OFFICERS,  PROMOTERS,  CONTROL  PERSONS  AND  CORPORATE  GOVERNANCE;
COMPLIANCE WITH SECTION 16(a) OF THE EXCHANGE ACT

PART III

The name, age and positions of our directors and executive officers are set forth below:

Name

Age

  Position

Stephen C. Haley

Jan Norelid

Jeffrey Perlman

Janice Haley

James Cast

William Milmoe

Geary Cotton

51

55

44

46

60

60

57

  Chief Executive Officer, President and Chairman of the Board of Directors

  Chief Financial Officer and Director

  Chief Operating Officer

  Vice President of Marketing

  Director

  Director

  Director

Set forth below is a brief description of the background and business experience of each of our executive officers and directors.

Stephen C. Haley is Chief Executive Officer, President and Chairman of the Board of Directors for the Company, and has served in this capacity since he founded
Elite in 2004. Elite merged into the Company’s subsidiary, Celsius, Inc. on January 26, 2007.  Prior to founding Elite, from 2001 to 2004, Mr. Haley invested in multiple
companies including the beverage industry. From 1999 to 2001, he held positions as COO and Chief Business Strategist for MAPICS, a publicly held, international
software company with over five hundred (500) employees and $145 million in revenue. From 1997 to 1999, he was CEO of Pivotpoint, a Boston based Enterprise
Requirements Planning (ERP) software firm, backed by a venture group including Goldman Sachs, TA Associates, and Greyloc. He holds a BSBA in Marketing from
the University of Florida.

Jan Norelid is the Chief Financial Officer and a director of the Company.  He joined Elite as Chief Financial Officer in November 2006. Mr. Norelid has twenty-
seven (27) years of local and international financial experience. Most recently, from 2005 to 2006 he worked as consultant for Bioheart Inc, a start-up bio-medical
company,  and  FAS  Group,  a  consulting  firm  specialized  in  SEC  related  matters.  Previously,  from  September  1997  to  January  2005,  Mr.  Norelid  served  as  Chief
Financial Officer for Devcon International Corp, an $80 million NASDAQ listed company which manufactures building materials and provides a comprehensive range
of heavy-construction and support services. From January 1996 to September 1997, Mr. Norelid owned and operated a printing franchise. Prior to this, from 1990 to
1995, Mr. Norelid worked as Chief Financial Officer for Althin Medical Inc., a $100 million public medical device company. Previous experience since 1977 consisted
of  various  controller  and  CFO  positions  for  Swedish  companies,  stationed  in  six  different  countries  in  four  continents.  Mr.  Norelid  holds  a  degree  in  Business
Administration from the Stockholm School of Economics.

50

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Jeffrey Perlman is the Chief Operating Officer of the Company.  Mr. Perlman joined Celsius as Chief Operating Officer in January 2009. Since 2002 and until 2008
Mr. Perlman was President of Community Ventures Inc., a consulting firm offering business development, public relations, government relations, strategic planning,
publishing and economic development services. Mr. Perlman is the former mayor of the City of Delray Beach. Mr. Perlman is member of the board of directors for
the Business Development Board of Palm Beach County, the Greater Delray Beach Chamber of Commerce and several other non-profit organizations. Mr. Perlman
holds a BA in Political Science from the State University of New York, College at Oswego.

Janice Haley is the Vice President of Strategic Accounts and Business Development of the Company.  Ms. Haley joined Elite in 2006 as VP of Marketing. Prior to
joining Elite, from 2001 to 2006, Ms. Haley, together with her husband Stephen C. Haley, was an investor in beverage distribution and manufacturing companies. Ms.
Haley  has  over  twenty  (20)  years  management  expertise  including  the  software  technology  industry  in  enterprise  applications  and  manufacturing  industries
specializing in business strategy, sales and marketing. From 1999 to 2001 she was Director of Corporate Communications of Mapics, an international public software
company. Previously, from 1997 to 1999 she worked as VP of Marketing of Pivotpoint, a Boston based, venture-funded, software company. Ms. Haley began her
career in production in commercial and defense manufacturing firms such as ITT and Honeywell Inc.  Ms. Haley holds a BSBA in Marketing from University of
Florida.

James Cast is a director of the Company.  Mr. Cast joined Elite as director in 2007. Mr. Cast is a certified public accountant and is the owner of a CPA firm in Ft.
Lauderdale, Florida, which specializes in taxes and business consulting. Prior to forming his firm in 1994, Mr. Cast was senior tax Partner-in-Charge of KPMG Peat
Marwick’s  South  Florida  tax  practice  with  over  one  hundred  ten  (110)  employees.  During  his  twenty-two  (22)  years  at  KPMG  he  was  also  the  South  Florida
coordinator for all mergers, acquisitions, and business valuations. He is a member of AICPA and FICPA. He currently serves on the Board of the Covenant House
of Florida and is the former President of the Board of Trustees, First Presbyterian Church of Ft. Lauderdale. He has a BA from Austin College and a MBA from the
Wharton School at the University of Pennsylvania.

William Milmoe is a director of the  Company.   Mr.  Milmoe joined  Celsius  Holdings,  Inc as director in August 2008.  Mr.  Milmoe is president and chief financial
officer of CDS International Holdings, Inc., a position he has held since 2006. From 1997 to 2006, he was CDS’ chief financial officer and treasurer.  Mr. Milmoe is a
certified public accountant with over 30 years of broad business experience in both public accounting and private industry. His financial career has included positions
with PricewaterhouseCoopers, an internal public accounting firm, General Cinema Corporation, an independent bottler of Pepsi Cola and movie exhibitor.  Mr. Milmoe
is member of both the Florida and the American Institute of Certified Public Accountants.

Geary Cotton  is  a  director  of  the  Company.  Mr.  Cotton  joined  Celsius  Holdings,  Inc  as  director  in  September,  2008.  Mr.  Cotton  is  director  of  a  privately  held
insurance industry company, XN Financial. Mr. Cotton was from 1986 to 2000 chief financial officer of Rexall Sundown, and public entity sold in 2000 for $1.8 billion.
Mr. Cotton was a director and audit committee chairman of QEP Co. Inc. from 2002 to 2006. Mr. Cotton is a certified public accountant with over 30 years of broad
business experience in both public accounting and private industry. Mr. Cotton is a graduate of University of Florida.

51

 
 
 
 
 
 
ITEM 10.          EXECUTIVE COMPENSATION

The information required by this item is incorporated by reference to our definitive proxy statement or an amendment to this  Form 10-K to be filed not later than
120 days after the end of the fiscal year covered by this report.

ITEM 11.          SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER
MATTERS

Securities Authorized for Issuance under Equity Compensation Plans

The  following  table  sets  forth,  as  of  December  31,  2008,  certain  information  related  to  our  compensation  plans  under  which  shares  of  our  common  stock  are
authorized for issuance:

Number of securities to be
issued upon exercise of
outstanding options,
warrants and rights
(a)

Weighted-average exercise
price of outstanding options,
warrants and rights
(b)

13,447,317 
— 

13,447,317 

$

$

0.07 
— 

0.07 

Number of securities
remaining available for
future issuance under
equity compensation plans
(excluding securities
reflected in column (a))
(c)

2,474,833
—

2,474,833

Plan category

Equity compensation plans approved by security holders
Equity compensation plans not approved by security holders  

Total

Material Features of Plan Approved by Shareholders

On  January  18,  2007,  we  adopted  our  2006  Incentive  Stock  Plan.  The  2006  Incentive  Stock  Plan  provides  for  equity  incentives  to  be  granted  to  our  employees,
officers or directors or to key advisers or consultants. Equity incentives may be in the form of stock options with an exercise price not less than the fair market value
of the underlying shares as determined pursuant to the 2006 Incentive Stock Plan, stock appreciation rights, restricted stock awards, stock bonus awards, other stock-
based awards, or any combination of the foregoing. The 2006 Incentive Stock Plan is administered by the Compensation Committee of the Board of Directors. In the
absence  of  such  committee,  the  Board  of  Directors  administers  the  plan.  The  2006  Incentive  Stock  Plan  was  approved  by  our  stockholders  at  the  shareholders’
annual meeting on January 18, 2007.

Material Features of Individual Arrangements Not Approved by Shareholders

As of December 31, 2008, we do not have any individual equity compensation arrangements outside of our 2006 Incentive Stock Plan.

52

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The remaining information required by this item is incorporated by reference to our definitive proxy statement or an amendment to this Form 10-K to be filed not later
than 120 days after the end of the fiscal year covered by this report.

         CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

The information required by this item is incorporated by reference to our definitive proxy statement or an amendment to this  Form 10-K to be filed not later than
120 days after the end of the fiscal year covered by this report.

         EXHIBITS

The exhibits listed in the accompanying Exhibit Index are filed as part of this Annual Report on Form 10-K.

(a) Exhibits

Exhibit No. Description
2.1

Agreement and Plan of Reorganization dated
January 26, 2007
Articles of Merger

2.2

3.1

3.2

3.3

4.1

4.2

10.1

10.2

10.3

10.4

10.5

Articles of Incorporation

Bylaws

Articles of Amendment

Warrant Agreement with Investa Partners LLC

Stock Option Plan Adopted

Stock Grant Agreement Gregory Horn

Promissory Note to Special Nutrition Group, Inc.

Employment Agreement with Stephen Haley,
as amended
Employment Agreement with Jan Norelid,
as amended
Employment Agreement with Richard McGee,
as amended

Location
Incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K as filed
with the SEC on February 2, 2007
Incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K as  filed
with the SEC on February 2, 2007
Incorporated by reference to Exhibit 3.1 to the Company’s Registration Statement on Form SB-2
as filed with the SEC on November 21, 2005
Incorporated by reference to Exhibit B to the Company’s Information on Form DEF-14C as filed
with the SEC on December 5, 2006
Incorporated by reference to Exhibit A to the Company’s Information on Form DEF-14C as filed
with the SEC on December 5, 2006
Incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K as filed
with the SEC on February 2, 2007
Incorporated by  reference  to  Exhibit  4.5  to  the  Company’s  Current  Report  on  Form  8-K filed
with the SEC on February 2, 2007
Incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K as filed
with the SEC on February 2, 2007
Incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K as filed
with the SEC on February 2, 2007
Incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K as filed
with the SEC on July 16, 2007
Incorporated by reference to Exhibit 10.4 to  the Company’s Current Report on Form 8-K as filed
with the SEC on July 16, 2007
Incorporated by reference to Exhibit 10.5 to the Company’s Current Report on Form 8-K as filed
with the SEC on July 16, 2007

53

 
 
 
 
 
 
 
 
 
10.6

10.7

10.8

10.9

10.11

10.12

10.13

10.14

10.15

10.16

10.17

10.18

10.19

10.20

14.1

22.1
99.1

Employment Agreement with Janice Haley

Incorporated by reference to Exhibit 10.6 to the Company’s Current Report on Form 8-K as filed
with the SEC on February 2, 2007

Stock Grant Agreement Addendum 1 with Jan NorelidIncorporated by reference to Exhibit 10.1 to the Company’s Quarterly Report on Form 10-QSB

Common Stock Purchase Agreement with Fusion
Capital Fund II, LLC
Registration Rights Agreement with Fusion Capital
Fund II, LLC
Master Purchase and Sale Agreement (factoring
agreement) with Bibby Financial Services, Inc.
Promissory note issued to CD Financial, LLC dated
December 18, 2007 , as amended
Secured promissory note issued by Golden Gate
Investors, Inc. dated December 19, 2007
Secured purchase agreement between Celsius
Holdings, Inc. and Golden Gate Investors, Inc.
dated December 19, 2007
7 ¾% Convertible Debenture issued by Celsius
Holdings, Inc. dated December 19, 2007
Securities purchase agreement between Celsius
Holdings, Inc. and CDS Ventures of South Florida,
LLC. dated August 8, 2008
Registration rights agreement between Celsius
Holdings, Inc. and CDS Ventures of South Florida,
LLC. dated August 8, 2008
Loan and Security Agreement between Celsius, Inc
and CD Financial, LLC.
Securities purchase agreement between Celsius
Holdings, Inc. and CDS Ventures of South Florida,
LLC. dated December 12, 2008
Registration rights agreement between Celsius
Holdings, Inc. and CDS Ventures of South Florida,
LLC. dated December 12, 2008
Code of Ethical Conduct

List of subsidiaries
Results from Clinical Studies

as filed with the SEC on May 15, 2007
Incorporated by reference to  Exhibit 10.1 to the Company’s Current Report on Form 8-K as filed
with the SEC on June 25, 2007
Incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K as filed
with the SEC on June 25, 2007
Incorporated by reference to Exhibit 10.11 to the Company’s filing of Form SB-2/A as filed with
the SEC on August 28, 2007
Incorporated by reference to Exhibit 10.12 to the Company’s filing of Form 10-KSB as filed with
the SEC on March 3, 2008
Incorporated by reference to Exhibit 10.2 to the Company’s filing of Form 8-K/A as filed with the
SEC on January 9, 2008
Incorporated by reference to Exhibit 10.3 to the Company’s filing of Form 8-K/A as filed with the
SEC on January 9, 2008

Incorporated by reference to Exhibit 10.4 to the Company’s filing of Form 8-K/A as filed with the
SEC on January 9, 2008
Incorporated by reference to Exhibit 10.1 to the Company’s filing of Form 8-K as filed with the
SEC on August 12, 2008

Incorporated by reference to Exhibit 10.2 to the Company’s filing of Form 8-K as filed with the
SEC on August 12, 2008

Incorporated by reference to Exhibit 10.2 to the Company’s filing of Form 8-K as filed with the
SEC on December 10, 2008
Incorporated by reference to Exhibit 10.1 to the Company’s filing of Form 8-K as filed with the
SEC on December 17, 2008

Incorporated by reference to Exhibit 10.2 to the Company’s filing of Form 8-K as filed with the
SEC on December 17, 2008

Incorporated by reference to Exhibit 14.1 to the Company’s Original filing of Form SB-2 as filed
with the SEC on July 20, 2007
Filed herewith
Incorporated by reference to Exhibit 99.1 to the Company’s Original filing of Form SB-2 as filed
with the SEC on July 20, 2007

54

 
 
         PRINCIPAL ACCOUNTING FEES AND SERVICES

Audit Fees

The aggregate fees billed by the independent accountants or accrued for the fiscal years ended December 31, 2008 and 2007 for professional services for the audit of
the  Company's  annual  financial  statements  and  the  reviews  included  in  the  Company's  Form  10-Q  and  services  that  are  normally  provided  by  the  accountants  in
connection with statutory and regulatory filings or engagements for those fiscal years were $50,500 and $31,000, respectively.

Audit-Related Fees

The  aggregate  fees  billed  in  each  of  the  last  two  fiscal  years  for  assurance  and  related  services  by  the  principal  accountants  that  are  reasonably  related  to  the
performance of the audit or review of the Company's financial statements and are not reported under Item 9 (e)(1) of Schedule 14A was $0.

Tax Fees

The aggregate fees billed in each of the last two fiscal years for professional services rendered by the principal accountants for tax compliance, tax advice, and tax
planning was $0 and $1,250 during the years ended December 31, 2008 and 2007, respectively.

All Other Fees

During the last two fiscal years there were no other fees charged by the principal accountants other than those disclosed in (1) and (2) above.

Audit Committee

 We have not established an audit committee. Our board of directors approved the services rendered and fees charged by our independent auditors. Our board of
directors has reviewed and discussed our audited financial statements for the year ended December 31, 2008 with our management. In addition, our board of directors
has discussed with Sherb & Co, LLP, our independent registered public accountants, the matters required to be discussed by Statement of Auditing Standards No. 61
(Communications  with Audit  Committee).  Our  board  of  directors  also  has  received  the  written  disclosures  and  the  letter  from  as  required  by  the  Independence
Standards Board Standard No. 1 (Independence Discussions with Audit Committees) and our board of directors has discussed the independence of Sherb & Co, LLP
with that firm.

Based on our board of directors’ review of the matters noted above and its discussions with our independent auditors and our management, our board of directors
approved that the audited financial statements be included in our annual report on Form 10-K for the year ended December 31, 2008.

Policy for Pre-Approval of Audit and Non-Audit Services

Our board of directors’ policy is to pre-approve all audit services and all non-audit services that our independent auditor is permitted to perform for us under applicable
federal securities regulations. As permitted by the applicable regulations, our board of directors’ policy utilizes a combination of specific pre-approval on a case-by-
case basis of individual engagements of the independent auditor and general pre-approval of certain categories of engagements up to predetermined dollar thresholds
that are reviewed annually by our board of directors. Specific pre-approval is mandatory for the annual financial statement audit engagement, among others.

55

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.

SIGNATURES

Dated: March 6, 2009

CELSIUS HOLDINGS, INC.

/s/  Stephen C. Haley      
Stephen C. Haley
Chairman and Chief Executive Officer
(Principal Executive Officer)

In accordance with Exchange Act, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates
indicated.

Name

Title

/s/  Stephen C. Haley
Stephen C. Haley      

Chairman and Chief Executive Officer
(Principal Executive Officer)

/s/  Jan A. Norelid
Jan A. Norelid

/s/  James R. Cast
James R. Cast

/s/  William H. Milmoe
William H. Milmoe

/s/  Geary W. Cotton
Geary W. Cotton

Vice President and Chief Financial Officer
(Principal Financial and Accounting Officer)

Director

Director

Director

56

Date

March 6, 2009

March 6, 2009

March 6, 2009

March 6, 2009

March 6, 2009

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
EXHIBIT INDEX

Exhibit
No.

Title

22.1
31.1 
31.2
32.1
32.2

List of subsidiaries
Section 302 Certification of Chief Executive Officer
Section 302 Certification of Chief Financial Officer
Section 906 Certification of Chief Executive Officer
Section 906 Certification of Chief Financial Officer

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Exhibit 22.1

List of subsidiaries:

Celsius, Inc
Celsius Netshipments, Inc

 
 
 
 
 
Exhibit 31.1

I, Stephen C. Haley, certify that:

CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002

1.

2.

3.

4.

I have reviewed this Form 10-K of Celsius Holdings, Inc.;

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial
condition, results of operations and cash flows of the small business issuer as of, and for, the periods present in this report;

The small business issuer's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13-a-15(f) and 15d-15(f)) for
the small business issuer and have:

a)

b)

c)

d)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure
that  material  information  relating  to  the  small  business  issuer,  including its  consolidated  subsidiaries,  is  made  known  to  us  by  others  within  those
entities, particularly during the period in which this report is being prepared;

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to
provide  reasonable  assurance  regarding  the  reliability  of  financial reporting  and  the  preparation  of  financial  statements  for  external purposes  in
accordance with generally accepted accounting principals;

Evaluated the effectiveness of the small business issuer's disclosure controls and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

Disclosed in  this  report  any  change  in  the  small  business  issuer's  internal  control over  financing  reporting  that  occurred  during  the  small  business
issuer's most recent fiscal quarter (the small business issuer's fourth fiscal quarter in the case of an annual report) that has materially affected, or is
reasonably likely to materially affect, the small business issuer's internal control over financial reporting; and

5.

The small business issuer's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to
the small business issuer's auditors and the audit committee of the small business issuer's board of directors (or persons performing the equivalent functions):

a)

b)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely
to adversely affect the small business issuer's ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involved management or other employees who have a significant role in the small business issuer's internal
control over financial reporting.

Dated:    March 6, 2009
/s/    Stephen C. Haley
Stephen C. Haley
Chief Executive Officer

 
 
 
 
 
 
 
 
 
 
Exhibit 31.2

I, Jan A. Norelid, certify that:

CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002

1.

2.

3.

4.

I have reviewed this Form 10-K of Celsius Holdings, Inc.;

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial
condition, results of operations and cash flows of the small business issuer as of, and for, the periods present in this report;

The small business issuer's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13-a-15(f) and 15d-15(f)) for
the small business issuer and have:

a)

b)

c)

d)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure
that  material  information  relating  to  the  small  business  issuer,  including its  consolidated  subsidiaries,  is  made  known  to  us  by  others  within  those
entities, particularly during the period in which this report is being prepared;

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to
provide  reasonable  assurance  regarding  the  reliability  of  financial reporting  and  the  preparation  of  financial  statements  for  external purposes  in
accordance with generally accepted accounting principals;

Evaluated the effectiveness of the small business issuer's disclosure controls and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

Disclosed in  this  report  any  change  in  the  small  business  issuer's  internal  control over  financing  reporting  that  occurred  during  the  small  business
issuer's most recent fiscal quarter (the small business issuer's fourth fiscal quarter in the case of an annual report) that has materially affected, or is
reasonably likely to materially affect, the small business issuer's internal control over financial reporting; and

5.

The small business issuer's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to
the small business issuer's auditors and the audit committee of the small business issuer's board of directors (or persons performing the equivalent functions):

a)

b)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely
to adversely affect the small business issuer's ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involved management or other employees who have a significant role in the small business issuer's internal
control over financial reporting.

Dated:     March 6, 2009

/s/ Jan A. Norelid
Jan A. Norelid
Chief Financial Officer

 
 
 
 
 
 
 
 
 
 
Exhibit 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Celsius Holdings, Inc. (the "Company") on Form 10-K for the year ended December 31, 2008 as filed with the Securities and
Exchange Commission on the date hereof (the "Report"), I, Stephen C. Haley, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1.

2.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

A  signed  original  of  this  written  statement  required  by  Section  906  has  been  provided  to  the  Company  and  will  be  retained  by  the  Company  and  furnished  to  the
Securities and Exchange Commission or its staff upon request.

/s/  Stephen C. Haley
Stephen C. Haley
Chief Executive Officer

Dated:  March 6, 2009

 
 
 
 
 
Exhibit 32.2

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Celsius Holdings, Inc.(the "Company") on Form 10-K for the year ended December 31, 2008 as filed with the Securities and
Exchange  Commission  on  the  date  hereof  (the  "Report"),  I,  Jan  Norelid,  Chief  Financial  Officer  of  the  Company,  certify,  pursuant  to  18  U.S.C.  Section  1350,  as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1.

2.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

A  signed  original  of  this  written  statement  required  by  Section  906  has  been  provided  to  the  Company  and  will  be  retained  by  the  Company  and  furnished  to  the
Securities and Exchange Commission or its staff upon request.

/s/ Jan A. Norelid
Jan A. Norelid
Chief Financial Officer

Dated:  March 6, 2009